1
|
Abzhandadze T, Hoang MT, Mo M, Mostafaei S, Jurado PG, Xu H, Johnell K, Von Euler M, Eriksdotter M, Garcia-Ptacek S. COVID-19 Pandemic and Stroke Care in Patients with Dementia Compared to Other Stroke Patients. J Am Med Dir Assoc 2024; 25:105011. [PMID: 38702044 DOI: 10.1016/j.jamda.2024.03.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Revised: 03/27/2024] [Accepted: 03/28/2024] [Indexed: 05/06/2024]
Abstract
OBJECTIVES The primary objective of this study was to examine the impact of the COVID-19 pandemic on the quality of stroke care for patients with preexisting dementia, compared with patients who had only stroke. The secondary aim was to investigate how the quality of stroke care changed during the pandemic and post-pandemic periods compared with the pre-pandemic period in patients with preexisting dementia. DESIGN A registry-based, nationwide cohort study in Sweden. SETTING AND PARTICIPANTS We included patients with a first stroke between 2019 and 2022, both with and without dementia. The study periods were defined as follows: pre-pandemic (January 1, 2019, to February 29, 2020), COVID-19 pandemic (March 1, 2020, to February 24, 2022), and post-COVID-19 pandemic period (February 25, 2022, to September 19, 2022). The outcomes examined were the following quality indicators of stroke care, suggested by the national guideline of stroke care in Sweden: stroke admission site, performance of swallowing assessment, reperfusion treatment, assessment for rehabilitation, and early supported discharge. METHODS The associations were studied through group comparisons and binary logistic regressions. RESULTS Of the 21,795 patients with strokes, 1357 had documented preexisting dementia, and 20,438 had stroke without a dementia diagnosis. Throughout all study periods, a significantly lower proportion of patients with stroke with preexisting dementia, compared with stroke-only patients, received reperfusion treatment, assessments for rehabilitation, and early supported discharge from stroke units. In the subgroup of stroke patients with preexisting dementia, no significant associations were found regarding the quality indicators of stroke care before, during, and after the pandemic. CONCLUSIONS AND IMPLICATIONS Disparities in quality of stroke care were observed between stroke patients with preexisting dementia and those with only stroke during the COVID-19 pandemic. However, there were no statistically significant differences in stroke care for patients with dementia across the pandemic.
Collapse
Affiliation(s)
- Tamar Abzhandadze
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden; Department of Occupational Therapy and Physiotherapy, Sahlgrenska University Hospital, Gothenburg, Sweden.
| | - Minh Tuan Hoang
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Minjia Mo
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
| | - Shayan Mostafaei
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Pol Grau Jurado
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
| | - Hong Xu
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
| | - Kristina Johnell
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Mia Von Euler
- Faculty of Medicine and Health, Department of Neurology and Rehabilitation, Örebro University, Örebro, Sweden
| | - Maria Eriksdotter
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden; Aging and Inflammation Theme, Karolinska University Hospital, Stockholm, Sweden
| | - Sara Garcia-Ptacek
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden; Aging and Inflammation Theme, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
2
|
Schutzmeier M, Brandstetter LS, Stangl S, Ahnert J, Grau A, Gerken L, Klingshirn H, Reuschenbach B, Skazel T, Kippnich M, Wurmb T, Heuschmann P, Haas K. Development and pilot-testing of an evidence-based quality indicator set for home mechanical ventilation care: the OVER-BEAS project. BMC Health Serv Res 2024; 24:152. [PMID: 38291412 PMCID: PMC10829274 DOI: 10.1186/s12913-024-10583-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 01/09/2024] [Indexed: 02/01/2024] Open
Abstract
BACKGROUND The number of patients depending on home mechanical ventilation (HMV) has increased substantially in Germany in recent years. These patients receive long-term care in different nursing facilities (nursing home, shared living community, private home). However, there are limited data available on the quality of care of HMV patients. The aim of the OVER-BEAS project was to identify quality indicators (QIs) of HMV care using an evidence-based approach. METHODS A multidisciplinary board consisting of professionals and experts of HMV provision compiled a set of QIs between March and September 2019. In a structured, transparent process a set of QIs covering structures, processes and outcome of HMV patient's care were proposed and evaluated based on the best available evidence. QIs were defined as relevant, reliable and valid measurements of the quality of HMV care and furthermore to be comprehensive and applicable in practice. RESULTS The experts proposed 40 QIs and consented a final set of 26 QIs. Based on the final set, questionnaires to document the QIs were developed: (1) to assess the quality and describe the structure of the nursing facility; and (2) to gather information on patient-related processes and outcomes. The feasibility of the questionnaires was tested in 5 nursing facilities treating HMV patients. The remarks from the nursing specialists were categorised in three groups: (1) term missing accuracy, (2) problem of understanding, and (3) not documented or documented elsewhere. Mean documentation time by the nursing specialists for one patient was 15 min. Based on this feedback, the questionnaires were finalised. CONCLUSIONS We proposed a set of QIs relating to long-term HMV care and developed two questionnaires to collect this information. In a pilot study, we found the set of questionnaires to be feasible in assessing the quality of HMV care according to current evidence. The development of standardised evidence-based QIs to evaluate HMV care is a step towards implementing a standardised quality assurance program to document the quality of care of HMV patients.
Collapse
Affiliation(s)
- Martha Schutzmeier
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany.
| | - Lilly Sophia Brandstetter
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany
| | - Stephanie Stangl
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany
| | - Jutta Ahnert
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany
| | - Anna Grau
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany
| | - Laura Gerken
- Catholic University of Applied Sciences Munich, Munich, Germany
| | | | | | - Tobias Skazel
- Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Subsection Emergency and Disaster Relief Medicine, University Hospital Würzburg, Würzburg, Germany
| | - Maximilian Kippnich
- Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Subsection Emergency and Disaster Relief Medicine, University Hospital Würzburg, Würzburg, Germany
| | - Thomas Wurmb
- Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Subsection Emergency and Disaster Relief Medicine, University Hospital Würzburg, Würzburg, Germany
| | - Peter Heuschmann
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany
- Clinical Trial Centre Würzburg, University Hospital Würzburg, Würzburg, Germany
| | - Kirsten Haas
- Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University Würzburg (JMU), Würzburg, Germany
| |
Collapse
|
3
|
De Cola MC, Ielo A, Corallo F, Pollina Addario S, Scondotto S, Allotta A, Fantaci G, Bramanti P, Ciurleo R. Development of a Set of Indicators for Measuring and Improving Quality of Rehabilitation Care after Ischemic Stroke. Healthcare (Basel) 2023; 11:2065. [PMID: 37510506 PMCID: PMC10378746 DOI: 10.3390/healthcare11142065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 07/18/2023] [Accepted: 07/18/2023] [Indexed: 07/30/2023] Open
Abstract
Stroke is the leading global cause of permanent disability and the second leading cause of dementia within the first year of the event. Systematic quality improvement interventions such as Audit & Feedback (A&F) can monitor and improve the performance of post-stroke care in conjunction with the use of quality indicators (QIs). The scientific literature shows limited studies on quality improvement and QIs design for poststroke rehabilitation. In Italy, the National Outcomes Evaluation Programme (PNE) annually provides several QIs concerning the acute wards. On the contrary, indicators for quality assessment of post-acute stroke rehabilitation are not available nationwide. In recent years, the Italian Ministry of Health has funded a national network project, the aim of which is to provide and evaluate the effectiveness of A&F strategies in healthcare improvement. Part of this project is the development of a set of IQs for ischemic stroke rehabilitation used to conduct an A&F. In this study, we describe the design and development process of these QIs from administrative databases and report the results of the pilot test conducted on a small sample of Sicilian rehabilitation facilities, comparing them from 2019 to 2021. Feedback from the participating centers was mainly positive, and the quality indicators were found to be comprehensible and appreciated. However, the study highlighted the need for better adherence to indicators measuring processes of rehabilitation care. The set of quality indicators presented in this study, relevant to inpatient settings, could be considered a starting point on which to base quality improvement initiatives both nationally and internationally.
Collapse
Affiliation(s)
| | - Augusto Ielo
- IRCCS Centro Neurolesi Bonino-Pulejo, 98124 Messina, Italy
| | | | - Sebastiano Pollina Addario
- Assessorato della Salute, Dipartimento Attività Sanitarie e Osservatorio Epidemiologico, 90145 Palermo, Italy
| | - Salvatore Scondotto
- Assessorato della Salute, Dipartimento Attività Sanitarie e Osservatorio Epidemiologico, 90145 Palermo, Italy
| | - Alessandra Allotta
- Assessorato della Salute, Dipartimento Attività Sanitarie e Osservatorio Epidemiologico, 90145 Palermo, Italy
| | - Giovanna Fantaci
- Assessorato della Salute, Dipartimento Attività Sanitarie e Osservatorio Epidemiologico, 90145 Palermo, Italy
| | - Placido Bramanti
- IRCCS Centro Neurolesi Bonino-Pulejo, 98124 Messina, Italy
- Faculty of Psychology, Università Degli Studi eCampus, Via Isimbardi 10, 22060 Novedrate, Italy
| | | |
Collapse
|
4
|
Brunssen A, Rücker V, Heuschmann P, Held J, Hermanek P, Berlis A, Hecht M, Berger K. Stroke care during the COVID-19 pandemic: Case numbers, treatments, and mortality in two large German stroke registries. Front Neurol 2022; 13:924271. [PMID: 35968290 PMCID: PMC9367687 DOI: 10.3389/fneur.2022.924271] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Accepted: 06/28/2022] [Indexed: 11/27/2022] Open
Abstract
Background and purpose At the beginning of the SARS-CoV-2 pandemic, an alarming decline in hospitalizations for stroke was reported in several countries, including Germany. We assessed hospitalization numbers and indicators of the quality of stroke care in 2020 during the pandemic containment measures. Materials and methods The analysis was based on data of two large stroke quality assurance registries in the north and the south of Germany (Qualitätssicherung Schlaganfall Nordwestdeutschland and Bayerische Arbeitsgemeinschaft für Qualitätssicherung in der stationären Versorgung). We included 395 hospitals with 467,931 documented cases in 2018–2020. The time interval between admission and thrombolysis, frequency of systemic thrombolysis and intra-arterial therapy (IAT), National Institutes of Health Stroke Scale (NIHSS) score on admission and in-hospital mortality were assessed. Changes in the second (Q2) and fourth (Q4) quarters of 2020 were compared to corresponding quarters in 2019 by chi-squared tests. Results Hospitalization numbers decreased in the two stroke registries by 8% and 10% in Q2 of 2020 and by 5% and 15% in Q4 of 2020 compared to the same quarters in 2019, respectively. The decline was particularly seen in women and patients with transient ischemic attacks. In cases with cerebral infarction, no increase in NIHSS scores on admission was observed, and the proportion of patients with a time interval between admission and thrombolysis of ≤60 min was unchanged. No clear pattern was found in the frequency of systemic thrombolysis and IAT. In one of the registries, in-hospital mortality of patients with cerebral infarction increased in Q2 of 2020 compared to Q2 of 2019. Conclusion Case numbers slightly decreased under pandemic conditions, while our quarterly analysis indicated that the quality of stroke care was largely unchanged throughout the year 2020.
Collapse
Affiliation(s)
- Alicia Brunssen
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
- *Correspondence: Alicia Brunssen
| | - Viktoria Rücker
- Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany
| | - Peter Heuschmann
- Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany
- Clinical Trial Center (P.U.H.), Würzburg University Hospital, Würzburg, Germany
| | - Jana Held
- Bavarian Working Party for Quality Assurance, Munich, Germany
| | - Peter Hermanek
- Bavarian Working Party for Quality Assurance, Munich, Germany
| | - Ansgar Berlis
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Augsburg, Germany
| | - Martin Hecht
- Department of Neurology, Bezirkskliniken Schwaben, Kaufbeuren, Germany
| | - Klaus Berger
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| |
Collapse
|
5
|
Vodencarevic A, Weingärtner M, Caro JJ, Ukalovic D, Zimmermann-Rittereiser M, Schwab S, Kolominsky-Rabas P. Prediction of Recurrent Ischemic Stroke Using Registry Data and Machine Learning Methods: The Erlangen Stroke Registry. Stroke 2022; 53:2299-2306. [PMID: 35360927 DOI: 10.1161/strokeaha.121.036557] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND There have been multiple efforts toward individual prediction of recurrent strokes based on structured clinical and imaging data using machine learning algorithms. Some of these efforts resulted in relatively accurate prediction models. However, acquiring clinical and imaging data is typically possible at provider sites only and is associated with additional costs. Therefore, we developed recurrent stroke prediction models based solely on data easily obtained from the patient at home. METHODS Data from 384 patients with ischemic stroke were obtained from the Erlangen Stroke Registry. Patients were followed at 3 and 12 months after first stroke and then annually, for about 2 years on average. Multiple machine learning algorithms were applied to train predictive models for estimating individual risk of recurrent stroke within 1 year. Double nested cross-validation was utilized for conservative performance estimation and models' learning capabilities were assessed by learning curves. Predicted probabilities were calibrated, and relative variable importance was assessed using explainable artificial intelligence techniques. RESULTS The best model achieved the area under the curve of 0.70 (95% CI, 0.64-0.76) and relatively good probability calibration. The most predictive factors included patient's family and housing circumstances, rehabilitative measures, age, high calorie diet, systolic and diastolic blood pressures, percutaneous endoscopic gastrotomy, number of family doctor's home visits, and patient's mental state. CONCLUSIONS Developing fairly accurate models for individual risk prediction of recurrent ischemic stroke within 1 year solely based on registry data is feasible. Such models could be applied in a home setting to provide an initial risk assessment and identify high-risk patients early.
Collapse
Affiliation(s)
| | - Michael Weingärtner
- Interdisciplinary Center for Health Technology Assessment (HTA) and Public Health, Friedrich-Alexander University Erlangen-Nürnberg, Germany (M.W.)
| | - J Jaime Caro
- Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada (J.J.C.).,Health Policy, London School of Economics, United Kingdom (J.J.C.)
| | - Dubravka Ukalovic
- Computed Tomography, Siemens Healthcare GmbH, Forchheim, Germany (D.U.)
| | | | - Stefan Schwab
- Department of Neurology, University Hospital Erlangen, Germany (S.S.)
| | - Peter Kolominsky-Rabas
- Interdisciplinary Center for Health Technology Assessment and Public Health, Friedrich-Alexander University Erlangen-Nürnberg, Germany (P.K.-R.)
| |
Collapse
|
6
|
Kainz A, Meisinger C, Linseisen J, Kirchberger I, Zickler P, Naumann M, Ertl M. Changes of Health-Related Quality of Life Within the 1st Year After Stroke-Results From a Prospective Stroke Cohort Study. Front Neurol 2021; 12:715313. [PMID: 34671308 PMCID: PMC8520951 DOI: 10.3389/fneur.2021.715313] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Accepted: 09/06/2021] [Indexed: 11/13/2022] Open
Abstract
Introduction: As prospective data on long-term patient-reported outcome measures (PROMs) to assess Health related Quality of Life (HRQoL) after stroke are still scarce, this study examined the long-term course of PROMs and investigated influential factors such as recanalization therapies. Materials and Methods: A total of 945 (mean age 69 years; 56% male) stroke patients were enrolled with a personal interview and chart review performed at index event. One hundred forty (15%) patients received thrombolysis (IVT) and 53 (5%) patients received endovascular therapy (ET) or both treatments as bridging therapy (BT). After 3 and 12 months, a follow-up was conducted using a postal questionnaire including subjective quality of life EQ-5D-5L (European Quality of Life 5 Dimensions). At all time-points, Modified Rankin Scale (mRS) was additionally used to quantify functional stroke severity. Differences between therapy groups were identified using post-hoc-tests. Linear and logistic regression analyses were used to identify predictors of outcomes. Results: Recanalization therapies were associated with significant improvements of NIHSS (National Institutes of Health Stroke Scale [regression coefficient IVT 1.21 (p = 0.01) and ET/BT 7.6; p = 0.001] and mRS (modified Rankin Scale) [regression coefficient IVT 0.83; p = 0.001 and ET/BT 2.0; p = 0.001] between admission and discharge compared to patients with stroke unit therapy only, with a trend toward improvement of EQ-5D after 12 months [regression coefficient 4.67 (p = 0.17)] with IVT. HRQoL was considerably impaired by stroke and increased steadily in 3- and 12-months follow-up in patients with (mean EQ-5D from 56 to 68) and without recanalization therapy (mean EQ-5D from 62 to 68). In severe strokes a major and significant improvement was only detected during period of 3 to 12 months (p = 0.03 in patients with and p = 0.005 in patients without recanalization therapy). Conclusions: Despite significant and continuous improvements after stroke the HRQoL after 12 months remained below the age-matched general population, but was still unexpectedly high in view of the accumulation of permanent disabilities in up to 30% of the patients. Especially in severe strokes, it is important to evaluate HRQoL beyond a 3-months follow-up as improvements became significant only between 3 months and 1 year.
Collapse
Affiliation(s)
- Anabelle Kainz
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Augsburg, Germany
| | - Christa Meisinger
- Chair of Epidemiology, University Augsburg, University Hospital Augsburg, Augsburg, Germany.,Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
| | - Jakob Linseisen
- Chair of Epidemiology, University Augsburg, University Hospital Augsburg, Augsburg, Germany.,Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
| | - Inge Kirchberger
- Chair of Epidemiology, University Augsburg, University Hospital Augsburg, Augsburg, Germany.,Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
| | - Philipp Zickler
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Augsburg, Germany
| | - Markus Naumann
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Augsburg, Germany
| | - Michael Ertl
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Augsburg, Germany
| |
Collapse
|
7
|
Alegiani A, Rosenkranz M, Schmitz L, Lezius S, Seidel G, Heßelmann V, Töpper R, Terborg C, Urban PP, Brüning R, Höltje J, Lienau F, Arning C, Marquardt L, Müller-Jensen A, Röther J, Eckert B, Zapf A, Fiehler J, Thomalla G, Gerloff C. Ten Years of Improving Acute Stroke Management in a Metropolitan Area: A Population-Based Quantification of Quality Indicators. Eur Neurol 2021; 85:39-49. [PMID: 34818228 DOI: 10.1159/000518428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2020] [Accepted: 07/11/2021] [Indexed: 11/19/2022]
Abstract
BACKGROUND AND PURPOSE Rapid access to acute stroke treatment improves clinical outcomes in patients with ischemic stroke. We aimed to shorten the time to admission and to acute stroke treatment for patients with acute stroke in the Hamburg metropolitan area by collaborative multilevel measures involving all hospitals with stroke units, the Emergency Medical Services (EMS), and health-care authorities. METHODS In 2007, an area-wide stroke care quality project was initiated. The project included mandatory admission of all stroke patients in Hamburg exclusively to hospitals with stroke units, harmonized acute treatment algorithms among all hospitals, repeated training of the EMS staff, a multimedia educational campaign, and a mandatory stroke care quality monitoring system based on structured data assessment and quality indicators for procedural measures. We analyzed data of all patients with acute stroke who received inhospital treatment in the city of Hamburg during the evaluation period from the quality assurance database data and evaluated trends of key quality indicators over time. RESULTS From 2007 to 2016, a total of 83,395 patients with acute stroke were registered. During this period, the proportion of patients admitted within ≤3 h from symptom onset increased over time from 27.8% in 2007 to 35.2% in 2016 (p < 0.001). The proportion of patients who received rapid thrombolysis (within ≤30 min after admission) increased from 7.7 to 54.1% (p < 0.001). CONCLUSIONS Collaborative stroke care quality projects are suitable and effective to improve acute stroke care.
Collapse
Affiliation(s)
- Anna Alegiani
- Department of Neurology, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Michael Rosenkranz
- Institute of Medical Biometry and Epidemiology University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Leonie Schmitz
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Susanne Lezius
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Günter Seidel
- Department of Neurology, Albertinen Krankenhaus, Hamburg, Germany
| | - Volker Heßelmann
- Department of Neurology and Neuroradiology, Asklepios Hospital Nord, Hamburg, Germany
| | - Rudolf Töpper
- Department of Neurology and Neuroradiology, Asklepios Hospital Nord, Hamburg, Germany
| | - Christoph Terborg
- Department of Neurology, Asklepios Hospital Harburg, Hamburg, Germany
| | - Peter P Urban
- Department of Neurology, Asklepios Hospital St. Georg, Hamburg, Germany
| | - Roland Brüning
- Department of Neurology and Radiology and Neuroradiology, Asklepios Hospital Barmbek, Hamburg, Germany
| | - Jan Höltje
- Department of Neurology and Radiology and Neuroradiology, Asklepios Hospital Barmbek, Hamburg, Germany
| | - Florian Lienau
- Department of Neurology, Asklepios Hospital Barmbek, Hamburg, Germany
| | | | - Lars Marquardt
- Asklepios Hospital Barmbek, Marienkrankenhaus, Hamburg, Germany
| | - Axel Müller-Jensen
- University Department of Neurology, Asklepios Hospital Hamburg Wandsbek, Faculty of Medicine, Semmelweis University Campus Hamburg, Hamburg, Germany
| | - Joachim Röther
- University Department of Neurology, Asklepios Hospital Hamburg Wandsbek, Faculty of Medicine, Semmelweis University Campus Hamburg, Hamburg, Germany
| | - Bernd Eckert
- Department of Neurology and Neuroradiology, Asklepios Hospital Altona, Hamburg, Germany
| | - Antonia Zapf
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Jens Fiehler
- Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Götz Thomalla
- Department of Neurology, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Christian Gerloff
- Department of Neurology, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
8
|
Novarro-Escudero N, Moon YJ, Olmedo A, Ferguson T, Caballero I, Onodera E, Effio E, Klein LM, Zink EK, Johnson B, Urrutia VC. Organization and Implementation of a Stroke Center in Panamá, a Model for Implementation of Stroke Centers in Low and Middle Income Countries. Front Neurol 2021; 12:684775. [PMID: 34484099 PMCID: PMC8415350 DOI: 10.3389/fneur.2021.684775] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Accepted: 07/21/2021] [Indexed: 11/13/2022] Open
Abstract
Background: Stroke is the second leading cause of death and disability worldwide. Stroke centers have become a central component of modern stroke services in many high-income countries, but their feasibility and efficacy in low, middle, and emerging high-income countries are less clear. Also, despite the availability of international guidelines, many hospitals worldwide do not have organized clinical stroke care. We present a methodology to help hospitals develop stroke centers and review quality data after implementation. Objectives: To describe and compare demographics, performance, and clinical outcomes of the Pacífica Salud, Hospital Punta Pacífica (PSHPP) stroke center during its first 3 years 2017–2019. Methods: Pacífica Salud, Hospital Punta Pacífica was organized to implement protocols of care based on the best practices by international guidelines and a quality improvement process. The methodology for implementation adapts a model for translating evidence into practice for implementation of evidence-based practices in medicine. This is a retrospective study of prospectively collected quality data between March of 2017 to December of 2019 for patients admitted to PSHPP with primary diagnosis stroke. Data collected include demographics, clinical data organized per the Joint Commission's STK Performance Measures, door to needle, door to groin puncture, 90 day modified Rankin Score, and hemorrhagic complications from IV thrombolysis and mechanical thrombectomy (MT). Primary outcome: year over year proficiency in documenting performance measures. Secondary outcome: year over year improvement. Results: A total of 143 patients were admitted for acute ischemic stroke, TIA, or hemorrhagic stroke. Of these, 36 were admitted in 2017, 50 in 2018, and 57 in 2019. Performance measure proficiency increased in the year-over-year analysis as did the total number of patients and the number of patients treated with IV thrombolysis and MT. Conclusions: We present the methodology and results of a stroke program implementation in Panamá. This program is the first in the country and in Central America to achieve Joint Commission International (JCI) certification as a Primary Stroke Center (PSC). We postulate that the dissemination of management guidelines is not sufficient to encourage the development of stroke centers. The application of a methodology for translation of evidence into practice with mentorship facilitated the success of this program.
Collapse
Affiliation(s)
| | - Yoon Ji Moon
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - Argelis Olmedo
- Department of Nursing and Quality, Pacífica Salud, Hospital Punta Pacífica, Panamá, Panama
| | - Teresa Ferguson
- Primary Stroke Center, Pacífica Salud, Hospital Punta Pacífica, Panamá, Panama
| | - Ileana Caballero
- Department of Emergency Medicine, Pacífica Salud, Hospital Punta Pacífica, Panamá, Panama
| | - Eduardo Onodera
- Department of Radiology, Pacífica Salud, Hospital Punta Pacífica, Panamá, Panama
| | - Euclides Effio
- Department of Neurosurgery, Pacífica Salud, Hospital Punta Pacífica, Panamá, Panama
| | - Lisa M Klein
- Department of Neurosciences, The Johns Hopkins Hospital Comprehensive Stroke Center, Baltimore, MD, United States
| | - Elizabeth K Zink
- Department of Neurosciences, The Johns Hopkins Hospital Comprehensive Stroke Center, Baltimore, MD, United States
| | - Brenda Johnson
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.,Department of Neurosciences, The Johns Hopkins Hospital Comprehensive Stroke Center, Baltimore, MD, United States
| | - Victor C Urrutia
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.,Department of Neurosciences, The Johns Hopkins Hospital Comprehensive Stroke Center, Baltimore, MD, United States
| |
Collapse
|
9
|
Kraft AK, Berger K. Quality of Care for Patients With Multiple Sclerosis-A Review of Existing Quality Indicators. Front Neurol 2021; 12:708723. [PMID: 34421807 PMCID: PMC8374044 DOI: 10.3389/fneur.2021.708723] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Accepted: 06/28/2021] [Indexed: 11/29/2022] Open
Abstract
Background: The care of patients with multiple sclerosis (MS) calls for a lifelong guidance and treatment and results in a high resource utilization. Therefore, strategies for the assessment and improvement of the care process are crucial. Quality indicators have become a widely used instrument to determine quality in many areas of the healthcare system. The currently available sets of indicators for the quality of MS care are summarized in this review. Methods: A literature search was conducted for reports that include statements on quality indicators for the care of people with MS. For the determination of the strength of the underlying evidence of the identified publications appropriate criteria of the PRISMA and AGREE-Statements were used. A further prioritization of the eligible indicators was based on the internal grading by the initial authors. Results: Of the 465 included records in the search, 6 sources were finally identified, 3 demonstrating a high and the others a medium strength of evidence. In total, these six reports described 226 quality indicators for the treatment of MS. Of them, 147 were further included in the assessment due to the scope of this article. Among the 101 indicators that originated from reports with a high strength of evidence, 6 also had a high initial internal grading. These six identified quality indicators describe five important characteristics of a high-quality care of MS. Conclusion: The search led to a scientifically evident set of six quality indicators for the assessment of care for patients with MS. These should be seen as starting points in the development of comprehensive sets of quality indicators in MS that addresses the individual objective of their use.
Collapse
Affiliation(s)
- Anna Kristina Kraft
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - Klaus Berger
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| |
Collapse
|
10
|
Nordanstig A, Curtze S, Gensicke H, Zinkstok SM, Erdur H, Karlsson C, Karlsson JE, Martinez-Majander N, Sibolt G, Lyrer P, Traenka C, Baharoglu MI, Scheitz JF, Bricout N, Hénon H, Leys D, Eskandari A, Michel P, Hametner C, Ringleb PA, Arnold M, Fischer U, Sarikaya H, Seiffge DJ, Pezzini A, Zini A, Padjen V, Jovanovic DR, Luft A, Wegener S, Kellert L, Feil K, Kägi G, Rentzos A, Lappalainen K, Leker RR, Cohen JE, Gomori J, Brehm A, Liman J, Psychogios M, Kastrup A, Papanagiotou P, Gralla J, Magoni M, Majoie CBLM, Bohner G, Vukasinovic I, Cvetic V, Weber J, Kulcsar Z, Bendszus M, Möhlenbruch M, Ntaios G, Kapsalaki E, Jood K, Nolte CH, Nederkoorn PJJ, Engelter S, Strbian D, Tatlisumak T. EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry. BMJ Open 2021; 11:e042211. [PMID: 34373287 PMCID: PMC8354282 DOI: 10.1136/bmjopen-2020-042211] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
PURPOSE The Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration was a concerted effort initiated in 2010 with the purpose to address relevant research questions about the effectiveness and safety of intravenous thrombolysis (IVT). The collaboration also aims to prospectively collect data on patients undergoing endovascular treatment (EVT) and hence the name of the collaboration was changed from TRISP to EVA-TRISP. The methodology of the former TRISP registry for patients treated with IVT has already been published. This paper focuses on describing the EVT part of the registry. PARTICIPANTS All centres committed to collecting predefined variables on consecutive patients prospectively. We aim for accuracy and completeness of the data and to adapt local databases to investigate novel research questions. Herein, we introduce the methodology of a recently constructed academic investigator-initiated open collaboration EVT registry built as an extension of an existing IVT registry in patients with acute ischaemic stroke (AIS). FINDINGS TO DATE Currently, the EVA-TRISP network includes 20 stroke centres with considerable expertise in EVT and maintenance of high-quality hospital-based registries. Following several successful randomised controlled trials (RCTs), many important clinical questions remain unanswered in the (EVT) field and some of them will unlikely be investigated in future RCTs. Prospective registries with high-quality data on EVT-treated patients may help answering some of these unanswered issues, especially on safety and efficacy of EVT in specific patient subgroups. FUTURE PLANS This collaborative effort aims at addressing clinically important questions on safety and efficacy of EVT in conditions not covered by RCTs. The TRISP registry generated substantial novel data supporting stroke physicians in their daily decision making considering IVT candidate patients. While providing observational data on EVT in daily clinical practice, our future findings may likewise be hypothesis generating for future research as well as for quality improvement (on EVT). The collaboration welcomes participation of further centres willing to fulfill the commitment and the outlined requirements.
Collapse
Affiliation(s)
- Annika Nordanstig
- Department of Clinical Neurosciences Sahlgrenska Academy at University of Gothenburg, Sahlgrenska Academy, Goteborg, Sweden,Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Sami Curtze
- Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Henrik Gensicke
- Department of Neurology and Stroke Center, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Sanne M Zinkstok
- Department of Neurology, Amsterdam University Medical Centres, Amsterdam, The Netherlands
| | - Hebun Erdur
- Department of Neurology and Center for Stroke Research, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - Camilla Karlsson
- Department of Clinical Neurosciences Sahlgrenska Academy at University of Gothenburg, Sahlgrenska Academy, Goteborg, Sweden
| | - Jan-Erik Karlsson
- Department of Clinical Neurosciences Sahlgrenska Academy at University of Gothenburg, Sahlgrenska Academy, Goteborg, Sweden,Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | | | - Gerli Sibolt
- Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Philippe Lyrer
- Department of Neurology and Stroke Center, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Christopher Traenka
- Department of Neurology and Stroke Center, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Merih I Baharoglu
- Department of Neurology, Amsterdam University Medical Centres, Amsterdam, The Netherlands
| | - Jan F Scheitz
- Department of Neurology and Center for Stroke Research, Charite Universitatsmedizin Berlin Klinik fur Neurologie mit Experimenteller Neurologie, Berlin, Germany
| | | | - Hilde Hénon
- Department of Neurology, University of Lille, Lille, France
| | - Didier Leys
- Department of Neurology, University of Lille, Lille, France
| | - Ashraf Eskandari
- Department of Neurology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Patrik Michel
- Department of Neurology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Christian Hametner
- Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany
| | | | - Marcel Arnold
- Department of Neurology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Urs Fischer
- Department of Neurology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Hakan Sarikaya
- Department of Neurology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - David J Seiffge
- Department of Neurology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Alessandro Pezzini
- Department of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Brescia, Italy
| | - Andrea Zini
- Department of Neurology and Stroke Center, Maggiore Hospital, IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Visnja Padjen
- Neurology Clinic, Clinical Centre of Serbia, Belgrade, Clinical Center of Serbia, Beograd, Serbia
| | - Dejana R Jovanovic
- Neurology Clinic, Clinical Centre of Serbia, Belgrade, Clinical Center of Serbia, Beograd, Serbia,Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Andreas Luft
- Department of Neurology, University of Zurich, Zurich, Switzerland
| | - Susanne Wegener
- Department of Neurology, University of Zurich, Zurich, Switzerland
| | - Lars Kellert
- Department of Neurology, Ludwig-Maximilians-Universitat Munchen, Munchen, Germany
| | - Katharina Feil
- Neurology and German Center for Vertigo and Balance Disorders, Ludwig-Maximilians-Universitat Munchen, Munchen, Germany
| | - Georg Kägi
- Department of Neurology, Kantonsspital St Gallen, Sankt Gallen, Switzerland
| | - Alexandros Rentzos
- Department of Radiology, Institute of clinical sciences, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden,Diagnostic and Interventional Neuroradiology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Kimmo Lappalainen
- Department of Radiology, Helsinki University Central Hospital, Helsinki, Finland
| | - Ronen R Leker
- Department of Neurology, Hebrew University Hadassah Medical School, Yerushalayim, Israel
| | - Jose E Cohen
- Department of Neurosurgery, Hebrew University Hadassah Medical School, Yerushalayim, Israel
| | - John Gomori
- Department of Radiology, Hebrew University Hadassah Medical School, Yerushalayim, Israel
| | - Alex Brehm
- Department of Neurology, Georg-August-Universitat Gottingen Universitatsmedizin, Gottingen, Germany
| | - Jan Liman
- Department of Neurology, Georg-August-Universitat Gottingen Universitatsmedizin, Gottingen, Germany
| | - Marios Psychogios
- Department of Neuroradiology, Georg-August-Universitat Gottingen Universitatsmedizin, Gottingen, Germany,Neuroradiology and Stroke Center Basel, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Andreas Kastrup
- Department of Neurology, University Hospitals Bremen-Mitte and Bremen-Ost, Bremen, Germany
| | - Panagiotis Papanagiotou
- Clinic for Diagnostic and Interventional Neuroradiology, University Hospitals Bremen-Mitte and Bremen-Ost, University of Bremen, Bremen, Germany,Department of Radiology, Areteion University Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - Jan Gralla
- Institute of Diagnostic and Interventional Neuroradiology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Mauro Magoni
- USD Stroke Unit and Vascular Neurology, ASST Spedali Civili di Brescia, Brescia, Italy
| | - Charles B L M Majoie
- Department of Neuroradiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands
| | - Georg Bohner
- Institute of Neuroradiology, Charité-Universitätsmedizin, Berlin, Germany
| | - Ivan Vukasinovic
- Clinic of Neurosurgery, Clinical Center of Serbia, Beograd, Serbia
| | - Vladimir Cvetic
- Faculty of Medicine, University of Belgrade, Beograd, Serbia,Clinic for Vascular and Endovascular Surgery, Clinical Centre of Serbia, Belgrade, Serbia
| | - Johannes Weber
- Department of Radiology and Nuclear Medicine, Kantonsspital St Gallen, Sankt Gallen, Switzerland
| | - Zsolt Kulcsar
- Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland
| | - Martin Bendszus
- Department of Neuroradiology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany
| | - Markus Möhlenbruch
- Department of Neuroradiology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany
| | - George Ntaios
- Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Volos, Thessaly, Greece
| | - Eftychia Kapsalaki
- Department of Radiology, University Hospital of Larissa, School of Medicine, University of Thessaly, Volos, Thessaly, Greece
| | - Katarina Jood
- Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden,Department for Clinical Neuroscience and Rehabilitation, Sahlgrenska Academy, Goteborg, Sweden
| | - Christian H Nolte
- Department of Neurology and Center for Stroke Research, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - Paul J J Nederkoorn
- Department of Neurology, Amsterdam University Medical Centres, Amsterdam, The Netherlands
| | - Stefan Engelter
- Department of Neurology and Stroke Center, University of Basel, Basel, Switzerland,Deptartment of Radiology, Areteion University Hospital, National and Kapodistrian University of Athens, Athen, Greece
| | - Daniel Strbian
- Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Turgut Tatlisumak
- Department of Clinical Neurosciences, Sahlgrenska University Hospital, Goteborg, Sweden,Department of Neurology, University of Helsinki, Helsinki, Finland
| | | |
Collapse
|
11
|
Schang L, Blotenberg I, Boywitt D. What makes a good quality indicator set? A systematic review of criteria. Int J Qual Health Care 2021; 33:mzab107. [PMID: 34282841 PMCID: PMC8325455 DOI: 10.1093/intqhc/mzab107] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 06/09/2021] [Accepted: 07/19/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND While single indicators measure a specific aspect of quality (e.g. timely support during labour), users of these indicators, such as patients, providers and policy-makers, are typically interested in some broader construct (e.g. quality of maternity care) whose measurement requires a set of indicators. However, guidance on desirable properties of indicator sets is lacking. OBJECTIVE Based on the premise that a set of valid indicators does not guarantee a valid set of indicators, the aim of this review is 2-fold: First, we introduce content validity as a desirable property of indicator sets and review the extent to which studies in the peer-reviewed health care quality literature address this criterion. Second, to obtain a complete inventory of criteria, we examine what additional criteria of quality indicator sets were used so far. METHODS We searched the databases Web of Science, Medline, Cinahl and PsycInfo from inception to May 2021 and the reference lists of included studies. English- or German-language, peer-reviewed studies concerned with desirable characteristics of quality indicator sets were included. Applying qualitative content analysis, two authors independently coded the articles using a structured coding scheme and discussed conflicting codes until consensus was reached. RESULTS Of 366 studies screened, 62 were included in the review. Eighty-five per cent (53/62) of studies addressed at least one of the component criteria of content validity (content coverage, proportional representation and contamination) and 15% (9/62) addressed all component criteria. Studies used various content domains to structure the targeted construct (e.g. quality dimensions, elements of the care pathway and policy priorities), providing a framework to assess content validity. The review revealed four additional substantive criteria for indicator sets: cost of measurement (21% [13/62] of the included studies), prioritization of 'essential' indicators (21% [13/62]), avoidance of redundancy (13% [8/62]) and size of the set (15% [9/62]). Additionally, four procedural criteria were identified: stakeholder involvement (69% [43/62]), using a conceptual framework (44% [27/62]), defining the purpose of measurement (26% [16/62]) and transparency of the development process (8% [5/62]). CONCLUSION The concept of content validity and its component criteria help assessing whether conclusions based on a set of indicators are valid conclusions about the targeted construct. To develop a valid indicator set, careful definition of the targeted construct including its (sub-)domains is paramount. Developers of quality indicators should specify the purpose of measurement and consider trade-offs with other criteria for indicator sets whose application may reduce content validity (e.g. costs of measurement) in light thereof.
Collapse
Affiliation(s)
- Laura Schang
- Department of Methodology, Federal Institute for Quality Assurance and Transparency in Health Care (IQTIG), Katharina-Heinroth-Ufer 1, Berlin 10787, Germany
| | - Iris Blotenberg
- Department of Methodology, Federal Institute for Quality Assurance and Transparency in Health Care (IQTIG), Katharina-Heinroth-Ufer 1, Berlin 10787, Germany
| | - Dennis Boywitt
- Department of Methodology, Federal Institute for Quality Assurance and Transparency in Health Care (IQTIG), Katharina-Heinroth-Ufer 1, Berlin 10787, Germany
| |
Collapse
|
12
|
Bystritsky A, Spivak NM, Dang BH, Becerra SA, Distler MG, Jordan SE, Kuhn TP. Brain circuitry underlying the ABC model of anxiety. J Psychiatr Res 2021; 138:3-14. [PMID: 33798786 DOI: 10.1016/j.jpsychires.2021.03.030] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/24/2021] [Revised: 03/12/2021] [Accepted: 03/17/2021] [Indexed: 12/13/2022]
Abstract
Anxiety Disorders are prevalent and often chronic, recurrent conditions that reduce quality of life. The first-line treatments, such as serotonin reuptake inhibitors and cognitive behavioral therapy, leave a significant proportion of patients symptomatic. As psychiatry moves toward targeted circuit-based treatments, there is a need for a theory that unites the phenomenology of anxiety with its underlying neural circuits. The Alarm, Belief, Coping (ABC) theory of anxiety describes how the neural circuits associated with anxiety interact with each other and domains of the anxiety symptoms, both temporally and spatially. The latest advancements in neuroimaging techniques offer the ability to assess these circuits in vivo. Using Neurosynth, a large open-access meta-analytic imaging database, the association between terms related to specific neural circuits was explored within the ABC theory framework. Alarm-related terms were associated with the amygdala, anterior cingulum, insula, and bed nucleus of stria terminalis. Belief-related terms were associated with medial prefrontal cortex, precuneus, bilateral temporal poles, and hippocampus. Coping-related terms were associated with the ventrolateral and dorsolateral prefrontal cortices, basal ganglia, and anterior cingulate. Neural connections underlying the functional neuroanatomy of the ABC model were observed. Additionally, there was considerable interaction and overlap between circuits associated with the symptom domains. Further neuroimaging research is needed to explore the dynamic interaction between the functional domains of the ABC theory. This will pave the way for probing the neuroanatomical underpinnings of anxiety disorders and provide an evidence-based foundation for the development of targeted treatments, such as neuromodulation.
Collapse
Affiliation(s)
- Alexander Bystritsky
- Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA; BrainSonix Corporation, Sherman Oaks, CA, USA.
| | - Norman M Spivak
- Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA; Department of Neurosurgery, UCLA, Los Angeles, CA, USA; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
| | - Bianca H Dang
- Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA
| | - Sergio A Becerra
- Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA
| | - Margaret G Distler
- Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA
| | - Sheldon E Jordan
- Neurology Management Associates - Los Angeles, Santa Monica, CA, USA
| | - Taylor P Kuhn
- Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
| |
Collapse
|
13
|
Scherzer S, Robledo A, Stahl K, Nasri S, Kraft P. Number of Patients with Ischemic Stroke did not Decline in a Regional Stroke Unit After the Implementation of Mechanical Thrombectomy. J Stroke Cerebrovasc Dis 2020; 30:105498. [PMID: 33307293 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 11/16/2020] [Accepted: 11/20/2020] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES Since the implementation of mechanical thrombectomy (MT) in 2015 for patients with ischemic stroke and large-vessel occlusion, the question arose as to whether patients should be primarily admitted to the nearest regional stroke unit (SU) for prompt intravenous thrombolysis (IVT) or to a more distant supraregional SU performing MT, to avoid secondary-transfer delays in MT. Although an evidence-based answer is still lacking, a discrepant discussion with potential consequences for the regional flow of stroke patients arose. We aimed to assess if MT implementation was associated with the number and characteristics of patients with stroke/transient ischemic attack (TIA) admitted to a regional SU not offering endovascular treatment. MATERIALS AND METHODS Patients with acute stroke/TIA treated at the Klinikum Main-Spessart Lohr, Germany, in 2013/2014 or 2017/2018 were included in this retrospective study. Data were derived from the clinical information system and mandatory stroke quality assessment. We assessed the catchment area using a region-based approach. For each region, the number of patients treated in our hospital, including data regarding clinical severity, demographic characteristics, and changes over time, were analyzed. RESULTS The number of patients with acute stroke/TIA increased from 890 (2013/2014) to 1016 (2017/2018). Aggregated demographic and clinical data of the whole catchment area showed no differences between 2013/2014 and 2017/2018 (P > 0.05) besides duration of hospitalization (P < 0.01), IVT rate (P < 0.01), and secondary transfer for MT. A region-based analysis revealed an increase in younger and more severely affected patients admitted from the periphery of the catchment area between 2013/2014 and 2017/2018. CONCLUSION Despite the implementation of MT in the supraregional SUs around our regional SU (not offering MT), more patients with stroke/TIA were admitted to our hospital, especially younger and more severely affected patients, from the border regions of the catchment area.
Collapse
Affiliation(s)
- Stephan Scherzer
- Department of Neurology, Hospital Main-Spessart, Grafen-von-Rieneck-Str. 5, 97816 Lohr, Germany.
| | - Andrea Robledo
- Department of Neurology, Hospital Main-Spessart, Grafen-von-Rieneck-Str. 5, 97816 Lohr, Germany.
| | - Karin Stahl
- Department of Neurology, Hospital Main-Spessart, Grafen-von-Rieneck-Str. 5, 97816 Lohr, Germany.
| | - Sami Nasri
- Department of Neurology, Hospital Main-Spessart, Grafen-von-Rieneck-Str. 5, 97816 Lohr, Germany.
| | - Peter Kraft
- Department of Neurology, Hospital Main-Spessart, Grafen-von-Rieneck-Str. 5, 97816 Lohr, Germany; Department of Neurology, University Clinic Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany.
| |
Collapse
|
14
|
Haas K, Rücker V, Hermanek P, Misselwitz B, Berger K, Seidel G, Janssen A, Rode S, Burmeister C, Matthis C, Koennecke HC, Heuschmann PU. Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke. Stroke 2020; 51:3664-3672. [DOI: 10.1161/strokeaha.120.029968] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Background and Purpose:
Quality indicators (QI) are an accepted tool to measure performance of hospitals in routine care. We investigated the association between quality of acute stroke care defined by overall adherence to evidence-based QI and early outcome in German acute care hospitals.
Methods:
Patients with ischemic stroke admitted to one of the hospitals cooperating within the ADSR (German Stroke Register Study Group) were analyzed. The ADSR is a voluntary network of 9 regional stroke registers monitoring quality of acute stroke care across 736 hospitals in Germany. Quality of stroke care was defined by adherence to 11 evidence-based indicators of early processes of stroke care. The correlation between overall adherence to QI with outcome was investigated by assessing the association between 7-day in-hospital mortality with the proportion of QI fulfilled from the total number of QI the individual patient was eligible for. Generalized linear mixed model analysis was performed adjusted for the variables age, sex, National Institutes of Health Stroke Scale and living will and as random effect for the variable hospital.
Results:
Between 2015 and 2016, 388 012 patients with ischemic stroke were reported (median age 76 years, 52.4% male). Adherence to distinct QI ranged between 41.0% (thrombolysis in eligible patients) and 95.2% (early physiotherapy). Seven-day in-hospital mortality was 3.4%. The overall proportion of QI fulfilled was median 90% (interquartile range, 75%–100%). In multivariable analysis, a linear association between overall adherence to QI and 7-day in-hospital-mortality was observed (odds ratio adherence <50% versus 100%, 12.7 [95% CI, 11.8–13.7];
P
<0.001).
Conclusions:
Higher quality of care measured by adherence to a set of evidence-based process QI for the early phase of stroke treatment was associated with lower in-hospital mortality.
Collapse
Affiliation(s)
- Kirsten Haas
- Institute of Clinical Epidemiology and Biometry, University of Würzburg (K.H., V.R., P.U.H.)
| | - Viktoria Rücker
- Institute of Clinical Epidemiology and Biometry, University of Würzburg (K.H., V.R., P.U.H.)
| | - Peter Hermanek
- Bavarian Permanent Working Party for Quality Assurance (BAQ), Munich (P.H.)
| | | | - Klaus Berger
- Quality Assurance Project ”Stroke Register Northwest Germany”, Institute of Epidemiology and Social Medicine, University of Münster (K.B.)
| | - Günter Seidel
- Department of Neurology, Asklepios Klinik Nord, Hamburg (G.S.)
| | - Alfred Janssen
- Quality Assurance in Stroke Management in North Rhine–Westphalia, Medical Association North Rhine (A.J.)
| | - Susanne Rode
- Office for Quality Assurance in Health Care Baden-Württemberg GmbH (QiG BW GmbH), Stuttgart (S.R.)
| | | | - Christine Matthis
- Quality Association for Acute Stroke Treatment Schleswig-Holstein (QugSS), Institute of Social Medicine and Epidemiology, University of Lübeck (C.M.)
| | | | - Peter U. Heuschmann
- Institute of Clinical Epidemiology and Biometry, University of Würzburg (K.H., V.R., P.U.H.)
- Clinical Trial Center, University Hospital Würzburg (P.U.H.)
| | | |
Collapse
|
15
|
Ren N, Nishimura A, Kurogi A, Nishimura K, Matsuo R, Ogasawara K, Hashimoto Y, Higashi T, Sakai N, Toyoda K, Shiokawa Y, Tominaga T, Miyachi S, Kada A, Abe K, Ono K, Matsumizu K, Arimura K, Kitazono T, Miyamoto S, Minematsu K, Iihara K. Measuring Quality of Care for Ischemic Stroke Treated With Acute Reperfusion Therapy in Japan - The Close The Gap-Stroke. Circ J 2020; 85:201-209. [PMID: 33229795 DOI: 10.1253/circj.cj-20-0639] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND In Japan there is no consensus on how to efficiently measure quality indicators (QIs), defined as a standard of care, for acute ischemic stroke (AIS). Using information from a health insurance claims database and electronic medical records, we evaluated the feasibility and validity of measuring QIs for AIS patients who received intravenous recombinant tissue plasminogen activator (IV rt-PA) or endovascular therapy (EVT).Methods and Results:AIS patients receiving rt-PA or EVT between 2013 and 2015 were identified. We selected 17 AIS QI measures for primary stroke centers (PSCs) and 8 for comprehensive stroke centers (CSCs). Defined QIs were calculated for each hospital and then averaged. In total, the data of 8,206 patients (rt-PA 83.7%, EVT 34.9%) from 172 hospitals were obtained. Median National Institute of Health Stroke Scale score at admission was 14, and 37.7% of the patients were functionally independent at discharge. All target QIs were successfully measured with fewer missing values, and the accuracy of preset data was about 90%. Adherence rates were low (<50%) in 5 QI measures among PSCs, including door-to-needle time ≤1 h, and in 1 QI measure among CSCs (door-to-brain and vascular imaging time ≤30 min). CONCLUSIONS Measuring QIs for AIS by this novel approach was feasible and reliable in the provision of a national benchmark.
Collapse
Affiliation(s)
- Nice Ren
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Ataru Nishimura
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Ai Kurogi
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Kunihiro Nishimura
- Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center Hospital
| | - Ryu Matsuo
- Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University
| | | | | | - Takahiro Higashi
- Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center
| | - Nobuyuki Sakai
- Department of Neurosurgery, Kobe City Medical Center General Hospital
| | - Kazunori Toyoda
- Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center Hospital
| | | | - Teiji Tominaga
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
| | | | - Akiko Kada
- Department of Clinical Research Management, National Hospital Organization Nagoya Medical Center
| | - Keisuke Abe
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Kotaro Ono
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Kazunori Matsumizu
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Koichi Arimura
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Takanari Kitazono
- Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University
| | - Susumu Miyamoto
- Department of Neurosurgery, Kyoto University Graduate School of Medicine
| | - Kazuo Minematsu
- Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center Hospital
| | - Koji Iihara
- Director General, National Cerebral and Cardiovascular Center Hospital
| |
Collapse
|
16
|
Misselwitz B, Grau A, Berger K, Bruder I, Burmeister C, Hermanek P, Hohnhold R, Koennecke HC, Matthis C, Heuschmann PU. [Quality of care of acute ischemic stroke in Germany 2018]. DER NERVENARZT 2020; 91:484-492. [PMID: 32350547 DOI: 10.1007/s00115-020-00908-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
In this overview the current quality of acute in-hospital care of stroke patients in Germany in 2018 is described based on standardized and evidence-based quality indicators. For this purpose the reports of the regional quality assurance projects for stroke care, which collaborated within the German-speaking Stroke Registers Study Group (ADSR) were analyzed. Overall, more than 280,000 acute admissions of stroke patients were documented in the included quality assurance projects. The results regarding the defined 16 quality indicators comprising diagnostics, acute treatment, rehabilitation and secondary prevention showed a high level of acute inpatient treatment of stroke in Germany. Only a few quality indicators, such as early transfer for thrombectomy indicated a great necessity for process optimization.
Collapse
Affiliation(s)
- B Misselwitz
- Geschäftsstelle Qualitätssicherung Hessen (GQH), Frankfurter Str. 10-14, 65760, Eschborn, Deutschland.
| | - A Grau
- Neurologische Klinik mit Klinischer Neurophysiologie, Klinikum Ludwigshafen, Ludwigshafen, Deutschland
| | - K Berger
- Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Deutschland
| | - I Bruder
- Qualitätssicherung im Gesundheitswesen Baden-Württemberg GmbH (QiG), Stuttgart, Deutschland
| | | | - P Hermanek
- Bayerische Arbeitsgemeinschaft für Qualitätssicherung in der stationären Versorgung (BAQ), München, Deutschland
| | - R Hohnhold
- Externe Qualitätssicherung (EQS), Hamburg, Deutschland
| | - H C Koennecke
- Klinik für Neurologie - Stroke Unit, Vivantes Klinikum im Friedrichshain, Berlin, Deutschland
| | - C Matthis
- Institut für Sozialmedizin und Epidemiologie, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland
| | - P U Heuschmann
- Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg, Würzburg, Deutschland
| |
Collapse
|
17
|
Stangl S, Haas K, Eggers C, Reese JP, Tönges L, Volkmann J. [Care of patients with Parkinson's disease in Germany]. DER NERVENARZT 2020; 91:493-502. [PMID: 32189041 DOI: 10.1007/s00115-020-00890-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
In Germany various concepts for treating patients with Parkinson's disease (PD) are available, e.g. oral medication with levodopa or deep brain stimulation (DBS), depending on the stage and severity of symptoms and also multidisciplinary management up to intersectoral treatment approaches (e.g. complex PD treatment and integrative care concepts). Nevertheless, in the treatment of patients with PD a comprehensive provision of services and a nationwide standardized collation of treatment quality are so far lacking. This is particularly true for technically complicated procedures, which necessitate a high standard of expertise by the treating physician. Some of these challenges could be overcome by expanding digital approaches (e.g. teleneurological consultation and wearables) and by introducing quality assurance initiatives (e.g. comprehensive registries and certification programs).
Collapse
Affiliation(s)
- Stephanie Stangl
- Institut für Klinische Epidemiologie und Biometrie (IKE-B), Julius-Maximilians-Universität Würzburg, Würzburg, Deutschland
| | - Kirsten Haas
- Institut für Klinische Epidemiologie und Biometrie (IKE-B), Julius-Maximilians-Universität Würzburg, Würzburg, Deutschland
| | - Carsten Eggers
- Klinik für Neurologie, Universitätsklinikum Marburg, Philipps-Universität Marburg, Marburg, Deutschland
| | - Jens-Peter Reese
- Koordinierungszentrum für Klinische Studien, Philipps-Universität Marburg Fachbereich Medizin, Marburg, Deutschland
| | - Lars Tönges
- St. Josef-Hospital, Klinik für Neurologie, Ruhr-Universität Bochum, Bochum, Deutschland
| | - Jens Volkmann
- Neurologische Klinik und Poliklinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland.
| |
Collapse
|
18
|
Drynda S, Schindler W, Slagman A, Pollmanns J, Horenkamp-Sonntag D, Schirrmeister W, Otto R, Bienzeisler J, Greiner F, Drösler S, Lefering R, Hitzek J, Möckel M, Röhrig R, Swart E, Walcher F. Evaluation of outcome relevance of quality indicators in the emergency department (ENQuIRE): study protocol for a prospective multicentre cohort study. BMJ Open 2020; 10:e038776. [PMID: 32948571 PMCID: PMC7500312 DOI: 10.1136/bmjopen-2020-038776] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
INTRODUCTION Quality of emergency department (ED) care affects patient outcomes substantially. Quality indicators (QIs) for ED care are a major challenge due to the heterogeneity of patient populations, health care structures and processes in Germany. Although a number of quality measures are already in use, there is a paucity of data on the importance of these QIs on medium-term and long-term outcomes. The evaluation of outcome relevance of quality indicators in the emergency department study (ENQuIRE) aims to identify and investigate the relevance of QIs in the ED on patient outcomes in a 12-month follow-up. METHODS AND ANALYSIS The study is a prospective non-interventional multicentre cohort study conducted in 15 EDs throughout Germany. Included are all patients in 2019, who were ≥18 years of age, insured at the Techniker Krankenkasse (statutory health insurance (SHI)) and gave their written informed consent to the study.The primary objective of the study is to assess the effect of selected quality measures on patient outcome. The data collected for this purpose comprise medical records from the ED treatment, discharge (claims) data from hospitalised patients, a patient questionnaire to be answered 6-8 weeks after emergency admission, and outcome measures in a 12-month follow-up obtained as claims data from the SHI.Descriptive and analytical statistics will be applied to provide summaries about the characteristics of QIs and associations between quality measures and patient outcomes. ETHICS AND DISSEMINATION Approval of the leading ethics committee at the Medical Faculty of the University of Magdeburg (reference number 163/18 from 19 November 2018) has been obtained and adapted by responsible local ethics committees.The findings of this work will be disseminated by publication of peer-reviewed manuscripts and presentations as conference contributions (abstracts, poster or oral presentations).Moreover, results will be discussed with clinical experts and medical associations before being proposed for implementation into the quality management of EDs. TRIAL REGISTRATION NUMBER German Clinical Trials Registry (DRKS00015203); Pre-results.
Collapse
Affiliation(s)
- Susanne Drynda
- Department of Trauma Surgery, Otto von Guericke University, Magdeburg, Germany
| | - Wencke Schindler
- Institute of Social Medicine and Health Systems Research, Otto von Guericke University, Magdeburg, Germany
| | - Anna Slagman
- Emergency and Acute Medicine, Charité, Berlin, Germany
| | - Johannes Pollmanns
- Faculty of Health Care, Niederrhein University of Applied Sciences, Krefeld, Germany
| | | | | | - Ronny Otto
- Department of Trauma Surgery, Otto von Guericke University, Magdeburg, Germany
| | - Jonas Bienzeisler
- Institute of Medical Informatics, RWTH Aachen University, Aachen, Germany
| | - Felix Greiner
- Department of Trauma Surgery, Otto von Guericke University, Magdeburg, Germany
| | - Saskia Drösler
- Faculty of Health Care, Niederrhein University of Applied Sciences, Krefeld, Germany
| | - Rolf Lefering
- Institute for Research in Operative Medicine (IFOM), University of Witten/Herdecke, Köln, Germany
| | | | - Martin Möckel
- Emergency and Acute Medicine, Charité, Berlin, Germany
| | - Rainer Röhrig
- Institute of Medical Informatics, RWTH Aachen University, Aachen, Germany
| | - Enno Swart
- Institute of Social Medicine and Health Systems Research, Otto von Guericke University, Magdeburg, Germany
| | - Felix Walcher
- Department of Trauma Surgery, Otto von Guericke University, Magdeburg, Germany
| |
Collapse
|
19
|
Ertl M, Meisinger C, Linseisen J, Baumeister SE, Zickler P, Naumann M. Long-Term Outcomes in Patients with Stroke after in-Hospital Treatment-Study Protocol of the Prospective Stroke Cohort Augsburg (SCHANA Study). ACTA ACUST UNITED AC 2020; 56:medicina56060280. [PMID: 32517235 PMCID: PMC7353873 DOI: 10.3390/medicina56060280] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Revised: 05/29/2020] [Accepted: 06/03/2020] [Indexed: 01/19/2023]
Abstract
INTRODUCTION In Germany, stroke is the third leading cause of death, with more than 60,000 fatalities out of approximately 260,000 cases (first-ever and recurrent strokes) each year. So far, there are only a few long-term studies investigating determinants of the natural course of the disease, especially in the era of mechanical thrombectomy. MATERIALS AND METHODS The prospective single-center stroke cohort Augsburg (SCHANA) study will include about 1000 patients treated for stroke in the University Hospital of Augsburg. Patients aged 18 years or older with a confirmed diagnosis of ischemic or hemorrhagic stroke are included in the study. Information on demographic characteristics, onset of symptoms, etiologic factors, comorbidities, quality of life, invasive and non-invasive treatment, complications, and laboratory parameters are collected during a personal interview conducted during the patients' hospital stay and via a medical chart review. About 30 mL of blood is collected from each patient, and after processing and aliquoting, all blood specimens are frozen at -80° C. The study participants will be followed-up via postal questionnaires at three and 12 months after discharge from the hospital. Furthermore, mortality follow-ups will be conducted. Cox-regression analysis will be used to estimate relative risks. CONCLUSION The SCHANA study will generate comprehensive data on the long-term course of the disease. In addition to the main outcomes, recurrent events and survival, patient-oriented outcomes such as health-related quality of life and depression are the focus of the study.
Collapse
Affiliation(s)
- Michael Ertl
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany; (P.Z.); (M.N.)
- Correspondence: ; Tel.: +49-821-400-2991
| | - Christa Meisinger
- Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; (C.M.); (J.L.); (S.-E.B.)
- Chair of Epidemiology, Ludwig-Maximilians-Universität München, UNIKA-T Augsburg, Neusässer Str. 47, 86156 Augsburg, Germany
| | - Jakob Linseisen
- Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; (C.M.); (J.L.); (S.-E.B.)
- Chair of Epidemiology, Ludwig-Maximilians-Universität München, UNIKA-T Augsburg, Neusässer Str. 47, 86156 Augsburg, Germany
| | - Sebastian-Edgar Baumeister
- Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; (C.M.); (J.L.); (S.-E.B.)
| | - Philipp Zickler
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany; (P.Z.); (M.N.)
| | - Markus Naumann
- Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany; (P.Z.); (M.N.)
| |
Collapse
|
20
|
Two years' experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke). BMC Neurol 2020; 20:104. [PMID: 32192438 PMCID: PMC7081707 DOI: 10.1186/s12883-020-01676-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 03/05/2020] [Indexed: 11/10/2022] Open
Abstract
Background Telemedicine improves the quality of acute stroke care in rural regions with limited access to specialized stroke care. We report the first 2 years’ experience of implementing a comprehensive telemedical stroke network comprising all levels of stroke care in a defined region. Methods The TRANSIT-Stroke network covers a mainly rural region in north-western Bavaria (Germany). All hospitals providing acute stroke care in this region participate in TRANSIT-Stroke, including four hospitals with a supra-regional certified stroke unit (SU) care (level III), three of those providing teleconsultation to two hospitals with a regional certified SU (level II) and five hospitals without specialized SU care (level I). For a two-year-period (01/2015 to 12/2016), data of eight of these hospitals were available; 13 evidence-based quality indicators (QIs) related to processes during hospitalisation were evaluated quarterly and compared according to predefined target values between level-I- and level-II/III-hospitals. Results Overall, 7881 patients were included (mean age 74.6 years ±12.8; 48.4% female). In level-II/III-hospitals adherence of all QIs to predefined targets was high ab initio. In level-I-hospitals, three patterns of QI-development were observed: a) high adherence ab initio (31%), mainly in secondary stroke prevention; b) improvement over time (44%), predominantly related to stroke specific diagnosis and in-hospital organization; c) no clear time trends (25%). Overall, 10 out of 13 QIs reached predefined target values of quality of care at the end of the observation period. Conclusion The implementation of the comprehensive TRANSIT-Stroke network resulted in an improvement of quality of care in level-I-hospitals.
Collapse
|
21
|
Abstract
OBJECTIVE To examine national adherence to emergency general surgery (EGS) best practices. BACKGROUND There is a national crisis in access to high-quality care for general surgery emergencies. Acute care surgery (ACS), a specialty leveraging strengths of trauma systems, may ameliorate this crisis. A critical component of trauma care is adherence to clinical guidelines. We previously established best practices for EGS using RAND Appropriateness Methodology and pilot data. METHOD A hybrid (postal/electronic) questionnaire measuring adherence to 20 EGS best practices was administered to respondents overseeing EGS at all eligible adult acute care general hospitals across the US (N = 2811). Questionnaire responses were analyzed using bivariate methods and multiple logistic regression. RESULTS The response rate was 60.1%. Adherence ranged from 8.5% for having an EGS registry to 86.2% for auditing 30-day postoperative readmissions. Adherence was higher for practices not restricted to EGS (eg, auditing readmissions) compared to EGS-specific practices (eg, registry, activation system). Adopting an ACS model of care increased adherence to practices for deferring elective cases; tiering urgent operations; following National Comprehensive Cancer Network guidelines; reversing anticoagulants; auditing returns to intensive care, time to evaluation, time to operation, and time to source control; and having transfer agreements to receive patients, ICU admission protocols, as well as EGS-specific activation systems, outpatient clinics, morbidity and mortality conferences, and registries. CONCLUSIONS There is substantial room for performance improvement, and adopting an ACS model predicts better performance. This novel overview of adherence to EGS best practices will enable surgeons and policymakers to address variations in EGS care nationally.
Collapse
|
22
|
Nishimura A, Nishimura K, Onozuka D, Matsuo R, Kada A, Kamitani S, Higashi T, Ogasawara K, Shimodozono M, Harada M, Hashimoto Y, Hirano T, Hoshino H, Itabashi R, Itoh Y, Iwama T, Kohriyama T, Matsumaru Y, Osato T, Sasaki M, Shiokawa Y, Shimizu H, Takekawa H, Nishi T, Uno M, Yagita Y, Ido K, Kurogi A, Kurogi R, Arimura K, Ren N, Hagihara A, Takizawa S, Arai H, Kitazono T, Miyamoto S, Minematsu K, Iihara K. Development of Quality Indicators of Stroke Centers and Feasibility of Their Measurement Using a Nationwide Insurance Claims Database in Japan ― J-ASPECT Study ―. Circ J 2019; 83:2292-2302. [DOI: 10.1253/circj.cj-19-0089] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Ataru Nishimura
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Kunihiro Nishimura
- Statistics and Data Analysis, National Cerebral and Cardiovascular Center
| | - Daisuke Onozuka
- Department of Health Communication, Kyushu University Graduate School of Medical Sciences
| | - Ryu Matsuo
- Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University
| | - Akiko Kada
- Department of Clinical Research Management, National Hospital Organization Nagoya Medical Center
| | - Satoru Kamitani
- Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center
| | - Takahiro Higashi
- Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center
| | | | - Megumi Shimodozono
- Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences
| | - Masafumi Harada
- Department of Radiology, Tokushima University Graduate School of Medical Sciences
| | | | - Teruyuki Hirano
- Department of Stroke and Cerebrovascular Medicine, Kyorin University School of Medicine
| | | | | | - Yoshiaki Itoh
- Department of Neurology, Graduate School of Medicine, Osaka City University
| | - Toru Iwama
- Department of Neurosurgery, Gifu University Graduate School of Medicine
| | | | - Yuji Matsumaru
- Department of Neurosurgery, Faculty of Medicine, University of Tsukuba
| | | | - Makoto Sasaki
- Division of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University
| | | | - Hiroaki Shimizu
- Department of Neurosurgery, Akita University Graduate School of Medicine
| | | | - Toru Nishi
- Division of Neurosurgery, Saiseikai Kumamoto Hospital
| | - Masaaki Uno
- Department of Neurosurgery, Kawasaki Medical School
| | | | - Keisuke Ido
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Ai Kurogi
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Ryota Kurogi
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Koichi Arimura
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Nice Ren
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| | - Akihito Hagihara
- Department of Health Communication, Kyushu University Graduate School of Medical Sciences
| | - Shunya Takizawa
- Department of Neurology, Department of Internal Medicine, Tokai University School of Medicine
| | - Hajime Arai
- Department of Neurosurgery, Juntendo University School of Medicine
| | - Takanari Kitazono
- Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
| | - Susumu Miyamoto
- Department of Neurosurgery, Kyoto University Graduate School of Medicine
| | | | - Koji Iihara
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University
| |
Collapse
|
23
|
Rios-Zertuche D, Zúñiga-Brenes P, Palmisano E, Hernández B, Schaefer A, Johanns CK, Gonzalez-Marmol A, Mokdad AH, Iriarte E. Methods to measure quality of care and quality indicators through health facility surveys in low- and middle-income countries. Int J Qual Health Care 2019; 31:183-190. [PMID: 29917087 PMCID: PMC6464097 DOI: 10.1093/intqhc/mzy136] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2017] [Revised: 05/02/2018] [Accepted: 05/31/2018] [Indexed: 12/28/2022] Open
Abstract
Objective Present methods to measure standardized, replicable and comparable metrics to measure quality of medical care in low- and middle-income countries. Design We constructed quality indicators for maternal, neonatal and child care. To minimize reviewer judgment, we transformed criteria from check-lists into data points and decisions into conditional algorithms. Distinct criteria were established for each facility level and type of care. Indicators were linked to discharge diagnoses. We designed electronic abstraction tools using computer-assisted personal interviewing software. Setting We present results for data collected in the poorest areas of Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and the state of Chiapas in Mexico (January—October 2014). Results We collected data from 12 662 medical records. Indicators show variations of quality of care between and within countries. Routine interventions, such as quality antenatal care (ANC), immediate neonatal care and postpartum contraception, had low levels of compliance. Records that complied with quality ANC ranged from 68.8% [confidence interval (CI):64.5–72.9] in Costa Rica to 5.7% [CI:4.0–8.0] in Guatemala. Less than 25% of obstetric and neonatal complications were managed according to standards in all countries. Conclusions Our study underscores that, with adequate resources and technical expertise, collecting data for quality indicators at scale in low- and middle-income countries is possible. Our indicators offer a comparable, replicable and standardized framework to identify variations on quality of care. The indicators and methods described are highly transferable and could be used to measure quality of care in other countries.
Collapse
Affiliation(s)
- Diego Rios-Zertuche
- Salud Mesoamérica Initiative/Inter-American Development Bank, Calle 50, Edificio Tower Financial Center (Towerbank), Piso 23, Apartado postal: 0816-02900 zona 5, Panamá, Panamá
| | - Paola Zúñiga-Brenes
- Salud Mesoamérica Initiative/Inter-American Development Bank, Calle 50, Edificio Tower Financial Center (Towerbank), Piso 23, Apartado postal: 0816-02900 zona 5, Panamá, Panamá
| | - Erin Palmisano
- Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, 2301 Fifth Ave., Suite 600, Seattle, WA, USA
| | - Bernardo Hernández
- Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, 2301 Fifth Ave., Suite 600, Seattle, WA, USA
| | - Alexandra Schaefer
- Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, 2301 Fifth Ave., Suite 600, Seattle, WA, USA
| | - Casey K Johanns
- Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, 2301 Fifth Ave., Suite 600, Seattle, WA, USA
| | - Alvaro Gonzalez-Marmol
- Salud Mesoamérica Initiative/Inter-American Development Bank, Calle 50, Edificio Tower Financial Center (Towerbank), Piso 23, Apartado postal: 0816-02900 zona 5, Panamá, Panamá
| | - Ali H Mokdad
- Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, 2301 Fifth Ave., Suite 600, Seattle, WA, USA
| | - Emma Iriarte
- Salud Mesoamérica Initiative/Inter-American Development Bank, Calle 50, Edificio Tower Financial Center (Towerbank), Piso 23, Apartado postal: 0816-02900 zona 5, Panamá, Panamá
| |
Collapse
|
24
|
Miura S, Miyata R, Matsumoto S, Higashi T, Wakisaka Y, Ago T, Kitazono T, Iihara K, Shimodozono M. Quality Management Program of Stroke Rehabilitation Using Adherence to Guidelines: A Nationwide Initiative in Japan. J Stroke Cerebrovasc Dis 2019; 28:2434-2441. [PMID: 31301984 DOI: 10.1016/j.jstrokecerebrovasdis.2019.06.028] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Revised: 06/02/2019] [Accepted: 06/22/2019] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND AND AIM In recent years, interest in the quality of medical care has rapidly increased worldwide. However, quality indicators that contribute to establishing standard treatment in stroke medicine, especially rehabilitation, are not well-developed in Japan. Japan has established Kaifukuki (convalescent) rehabilitation wards, and the development of quality indicators for stroke rehabilitation in the convalescent phase is an urgent issue. METHODS We first reviewed the literature regarding quality indicators for stroke rehabilitation. Next, we extracted candidate indicators from identified reports and guidelines and surveyed educational hospitals certified by the Japanese Association of Rehabilitation Medicine. On the basis of the survey results, we reevaluated the suitability of the proposed indicators in discussions with an expert panel. RESULTS The questionnaire survey highlighted several important items that revealed there is room for improvement in adherence. For stroke rehabilitation in the convalescent phase, we adopted 15 indicators that were feasible as indicators to be used for comparisons between facilities, based on scoring by and opinions of the expert panel. These indicators measured structure (2 indicators), process (5 indicators), and outcome (8 indicators). CONCLUSION This is the first study to establish quality indicators to standardize stroke rehabilitation in Japan. We developed this set of 15 indicators using an evidence-based approach. However, many tasks remain for continuous quality improvement.
Collapse
Affiliation(s)
- Seiji Miura
- Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| | - Ryuji Miyata
- Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| | - Shuji Matsumoto
- Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan; Department of Rehabilitation and Physical Medicine, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
| | - Takahiro Higashi
- Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan
| | - Yoshinobu Wakisaka
- Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Tetsuro Ago
- Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Takanari Kitazono
- Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Koji Iihara
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Megumi Shimodozono
- Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
| |
Collapse
|
25
|
Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kühn AA, Krauss JK, Sixel-Döring F, von Eckardstein K, Deuschl G, Classen J, Winkler D, Voges J, Galazky I, Oertel W, Ceballos-Baumann AO, Lange M, Gharabaghi A, Weiss DT, Volkmann J, Heuschmann PU. Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry. Parkinsonism Relat Disord 2019; 60:3-9. [PMID: 30772278 DOI: 10.1016/j.parkreldis.2019.01.016] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Revised: 01/12/2019] [Accepted: 01/22/2019] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Deep Brain Stimulation (DBS) is a complex, invasive and cost-intensive therapy that requires a high level of expertise. To date, data on quality of DBS in clinical routine in the German health care system are lacking. METHODS The development of evidence-based QIs for DBS in PD patients was performed following a standardized process by a multidisciplinary board between 2014 and 2016. The process was initiated by the German Parkinson Society and followed international recommendations for developing QIs including: a systematic literature search; an appraisal of the published evidence; a consensus-based selection of the QI set; and a pilot study to assess the feasibility in implementing the QIs in clinical routine. RESULTS A set of 28 QIs for determining the quality of DBS in PD was established by the board covering different dimensions of health care quality (structure, process, and outcome) in different treatment phases of DBS care (pre-operative, peri-operative, and post-operative). Implementation in clinical practice was tested in a pilot study comprising three hospitals delivering DBS care. The feasibility of the QI set was evaluated positively by the participating physicians and hospitals. Mean time to document one patient was 25 min. The German-wide implementation of the defined indicator set within a dedicated quality registry (QualiPa) started in June 2016. CONCLUSION QIs are a necessary requirement to monitor hospital performance in DBS care. The evidence-based approach to develop the proposed indicator set is expected to assure transparency, acceptance and long-term applicability of the QI set in Germany.
Collapse
Affiliation(s)
- Kirsten Haas
- Institute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany
| | - Stephanie Stangl
- Institute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany
| | | | - Cordula Matthies
- Department of Neurosurgery, University Hospital Würzburg, Würzburg, Germany
| | - Doreen Gruber
- Kliniken Beelitz, Movement Disorder Clinic, Beelitz-Heilstätten, Germany
| | - Andrea A Kühn
- Department of Neurology, Movement Disorders and Neuromodulation Unit, Charité - University Medicine (CCM), Berlin, Germany
| | - Joachim K Krauss
- Department of Neurosurgery, Medical School Hannover, Hannover, Germany
| | - Friederike Sixel-Döring
- Paracelsus-Elena Hospital, Kassel, Germany; Department of Neurology, Philipps-University Marburg, Germany
| | - Kajetan von Eckardstein
- Department of Neurosurgery, University Medicine Göttingen, Georg-August University, Göttingen, Germany
| | - Günther Deuschl
- Department of Neurology, Christian-Albrecht-University, Kiel, Germany
| | - Joseph Classen
- Department of Neurology, University of Leipzig, Leipzig, Germany
| | - Dirk Winkler
- Faculty of Medicine, Department of Neurosurgery, University Clinic of Leipzig, Leipzig, Germany
| | - Jürgen Voges
- Leibniz Institute for Neurobiology, Magdeburg, Germany; Department of Stereotactic Neurosurgery, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
| | - Imke Galazky
- Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany
| | - Wolfgang Oertel
- Department of Neurology, Philipps-University Marburg, Germany
| | - Andres O Ceballos-Baumann
- Schön Klinik München Schwabing, Department of Neurology, Technische Universität München, München, Germany
| | - Max Lange
- Department of Neurosurgery, University of Regensburg, Medical Center, Regensburg, Germany
| | - Alireza Gharabaghi
- Division of Functional and Restorative Neurosurgery, Department of Neurosurgery, University of Tuebingen, Centre for Integrative Neuroscience (CIN), University of Tuebingen, Tuebingen, Germany
| | - Daniel T Weiss
- Centre of Neurology, Department for Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (HIH), University of Tübingen, Germany
| | - Jens Volkmann
- Department of Neurology, University of Würzburg, Würzburg, Germany.
| | - Peter U Heuschmann
- Institute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany; Comprehensive Heart Failure Center, University Würzburg, Clincial Trial Center Würzburg, University Hospital Würzburg, Germany
| |
Collapse
|
26
|
Camp PG, Cheung W. Are We Delivering Optimal Pulmonary Rehabilitation? The Importance of Quality Indicators in Evaluating Clinical Practice. Phys Ther 2018; 98:541-548. [PMID: 29635637 DOI: 10.1093/ptj/pzy046] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Accepted: 04/07/2018] [Indexed: 02/09/2023]
Abstract
Pulmonary rehabilitation (PR) is a complex intervention that has been shown to improve exercise capacity and quality of life, reduce dyspnea, and decrease the risk of exacerbations and hospitalization. Although the evidence for PR is strong, the translation of this evidence into clinical practice remains a challenge, and important gaps in care exist. To date, most research in PR has focused on questions related to treatment efficacy. Less attention has been paid to confirming whether the strong evidence base of PR has been effectively translated to this complex clinical setting. Policy makers and other stakeholders in PR are calling for the establishment of core standards and quality indicators in PR to evaluate existing programs and improve patient care. However, what are quality indicators, and how are they used? This Perspective explores quality assurance in the context of PR and introduces the concepts and uses of quality indicators that can be used to evaluate and improve the quality of care.
Collapse
Affiliation(s)
- Pat G Camp
- Department of Physical Therapy, Centre for Heart Lung Innovation, University of British Columbia, 166-1081 Burrard Street, Vancouver, BC, V6Z 1Y6 Canada
| | - Walden Cheung
- Department of Physical Therapy, University of British Columbia
| |
Collapse
|
27
|
Deljavan R, Farhoudi M, Sadeghi-Bazargani H. Stroke in-hospital survival and its predictors: the first results from Tabriz Stroke Registry of Iran. Int J Gen Med 2018; 11:233-240. [PMID: 29950884 PMCID: PMC6016014 DOI: 10.2147/ijgm.s158296] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVE The aim of this study was to determine the in-hospital survival of patients referred to the 2 stroke centers in North-West of Iran during a full seasonal year from April 2015. METHODS All the consecutive patients with stroke admitted to the 2 main stroke centers at Tabriz (Imam Reza University Hospital and Razi University Hospital) were recruited in this study. Stroke patients from both ischemic and hemorrhagic subtypes were selected based on the registry data and International Classification of Diseases, 10th edition. At admission, details of examination including vital signs, neurologic and systemic examination, Modified Rankin Scale, and Glasgow Coma Scale were recorded. Baseline hematological and biochemical parameter assessments as well as computerized tomographic scanning were conducted. Cox regression was used to investigate and detect potential predictors of in-hospital survival. RESULTS A total of 1,990 patients with stroke were studied. Males comprised 52.1% (1,036) of the subjects. The mean age of the patients was 65.8 years. Three hundred and fifty-seven (17.9%) patients had hemorrhagic stroke vs 1,633 (82.1%) with ischemic stroke. In-hospital case-fatality proportion was 12.5% (95% CI: 11.1-14). Based on modified Rankin Scale score at admission, 1,377 of 1,990 patients (69.2%) had a poor outcome (modified Rankin Scale score ≥3) at the admission time. The regression analysis showed that at least 7 variables could independently predict hospital survival of patients with stroke including age ≥65 years, higher admission modified Rankin Scale score, lower admission Glasgow Coma Scale score, hemorrhagic stroke nature, diabetes, having valvular heart disease, and having aspiration pneumonia. CONCLUSION The case-fatality of stroke in the present study setting is high and needs to be appropriately addressed through prevention or management of some of these factors such as diabetes, pneumonia, and valvular heart diseases.
Collapse
Affiliation(s)
- Reza Deljavan
- Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Mehdi Farhoudi
- Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | | |
Collapse
|
28
|
Breuer L, Schwab S. [Telemedicine in stroke care]. Med Klin Intensivmed Notfmed 2017; 112:687-694. [PMID: 28913684 DOI: 10.1007/s00063-017-0344-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 08/17/2017] [Indexed: 01/01/2023]
Abstract
Telemedicine is already widely used in many telestroke networks and ensures stroke treatment close to the patient's home in rural and medically underserved areas. This is particularly effective when telemedicine is integrated into a stroke unit concept. While telemedically based thrombolysis therapy has become routine practice for many years, practical implementation of comprehensive mechanical thrombectomy and the related processes remains challenging. The main tasks for the future further include development of a structured stroke aftercare system in neurologically underserved areas and permanent assurance of high-quality stroke care in telemedically connected sites.
Collapse
Affiliation(s)
- L Breuer
- Neurologische Klinik, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Deutschland.
| | - S Schwab
- Neurologische Klinik, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Deutschland
| |
Collapse
|
29
|
Lange MC, Braga GP, Nóvak EM, Harger R, Felippe MJDB, Canever M, Dall'Asta I, Rauen J, Bazan R, Zetola V. Key performance indicators for stroke from the Ministry of Health of Brazil: benchmarking and indicator parameters. ARQUIVOS DE NEURO-PSIQUIATRIA 2017; 75:354-358. [PMID: 28658404 DOI: 10.1590/0004-282x20170051] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 02/15/2017] [Indexed: 11/22/2022]
Abstract
Methods All 16 KPIs were analyzed, including the percentage of patients admitted to the stroke unit, venous thromboembolism prophylaxis in the first 48 hours after admission, pneumonia and hospital mortality due to stroke, and hospital discharge on antithrombotic therapy in patients without cardioembolic mechanism. Results Both centers admitted over 80% of the patients in their stroke unit. The incidence of venous thromboembolism prophylaxis was > 85%, that of in-hospital pneumonia was < 13%, the hospital mortality for stroke was < 15%, and the hospital discharge on antithrombotic therapy was > 70%. Conclusion Our results suggest using the parameters of all of the 16 KPIs required by the Ministry of Health of Brazil, and the present results for the two stroke units for future benchmarking.
Collapse
Affiliation(s)
- Marcos C Lange
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| | | | - Edison M Nóvak
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| | - Rodrigo Harger
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| | | | - Mariana Canever
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| | - Isabella Dall'Asta
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| | - Jordana Rauen
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| | - Rodrigo Bazan
- Universidade do Estado de São Paulo, Hospital das Clínicas, Botucatu SP, Brasil
| | - Viviane Zetola
- Universidade Federal do Paraná, Hospital de Clínicas, Curitiba PR, Brasil
| |
Collapse
|
30
|
Why We Need More and Better Cardiovascular Disease Quality Indicators. Can J Cardiol 2017; 33:416-419. [DOI: 10.1016/j.cjca.2016.10.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2016] [Revised: 10/31/2016] [Accepted: 10/31/2016] [Indexed: 01/22/2023] Open
|
31
|
Meyer S, Willms G, Broge B, Szecsenyi J. [Topic identification for cross-sectoral quality assurance in stroke and TIA treatment]. ZEITSCHRIFT FUR EVIDENZ, FORTBILDUNG UND QUALITAT IM GESUNDHEITSWESEN 2016; 115-116:1-9. [PMID: 27837955 DOI: 10.1016/j.zefq.2016.07.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2015] [Revised: 06/20/2016] [Accepted: 07/16/2016] [Indexed: 06/06/2023]
Abstract
The development of cross-sectoral quality assurance programs usually requires extensive topic identification. Illustrated by the complex processes of care for stroke and transient ischemic attacks (TIAs), a method for comprehensive topic identification is presented. The first step involves a thorough literature search in terms of systematic reviews, health technology assessments, guidelines, studies into healthcare delivery and the use of specific instruments. Routine data as well as epidemiologic studies are used to analyze the reality of service provision. In addition, experts are consulted to gain expertise concerning deficits of care, approaches to quality assurance and experience with existing quality assurance programs. Furthermore individual patient experiences are collected to add the patients' perceptions of care. Because of the limitation on the regulatory scope of Book V of the German Social Code, which, in this case, was necessary, another source of information was the legal framework and its impact on rescue chain, acute treatment and rehabilitation. Existent quality management systems, accreditations and quality assurance programs in prevention, acute treatment and rehabilitation have been searched in order to avoid any overlap with existing measures. After identifying a total of 71 quality targets according to deficits of care, recommendations for care and expert opinions in primary and secondary prevention, rescue chain, acute treatment, rehabilitation and supply of assistive equipment and therapies, respectively, the usability of instruments was tested. These instruments included case documentation, patient surveys and routine data. 14 quality targets proved to be reproducible by these instruments and were included in the recommendations for a cross-sectoral quality assurance program for stroke and TIA.
Collapse
Affiliation(s)
- Sven Meyer
- AQUA-Institut für angewandte Qualitätsförderung und Forschung GmbH, Göttingen, Deutschland.
| | - Gerald Willms
- AQUA-Institut für angewandte Qualitätsförderung und Forschung GmbH, Göttingen, Deutschland
| | - Björn Broge
- AQUA-Institut für angewandte Qualitätsförderung und Forschung GmbH, Göttingen, Deutschland
| | - Joachim Szecsenyi
- AQUA-Institut für angewandte Qualitätsförderung und Forschung GmbH, Göttingen, Deutschland
| |
Collapse
|
32
|
Abstract
AbstractObjective: Administrative data validation is essential for identifying biases and misclassification in research. The objective of this study was to determine the accuracy of diagnostic codes for acute stroke and transient ischemic attack (TIA) using the Ontario Stroke Registry (OSR) as the reference standard. Methods: We identified stroke and TIA events in inpatient and emergency department (ED) administrative data from eight regional stroke centres in Ontario, Canada, from April of 2006 through March of 2008 using ICD–10–CA codes for subarachnoid haemorrhage (I60, excluding I60.8), intracerebral haemorrhage (I61), ischemic (H34.1 and I63, excluding I63.6), unable to determine stroke (I64), and TIA (H34.0 and G45, excluding G45.4). We linked administrative data to the Ontario Stroke Registry and calculated sensitivity and positive predictive value (PPV). Results:: We identified 5,270 inpatient and 4,411 ED events from the administrative data. Inpatient administrative data had an overall sensitivity of 82.2% (95% confidence interval [CI95%]=81.0, 83.3) and a PPV of 68.8% (CI95%=67.5, 70.0) for the diagnosis of stroke, with notable differences observed by stroke type. Sensitivity for ischemic stroke increased from 66.5 to 79.6% with inclusion of I64. The sensitivity and PPV of ED administrative data for diagnosis of stroke were 56.8% (CI95%=54.8, 58.7) and 59.1% (CI95%=57.1, 61.1), respectively. For all stroke types, accuracy was greater in the inpatient data than in the ED data. Conclusion: The accuracy of stroke identification based on administrative data from stroke centres may be improved by including I64 in ischemic stroke type, and by considering only inpatient data.
Collapse
|
33
|
Zhao M, Yan Y, Yang N, Wang X, Tan F, Li J, Li X, Li G, Li J, Zhao Y, Cai Y. Evaluation of clinical pathway in acute ischemic stroke: A comparative study. Eur J Integr Med 2016. [DOI: 10.1016/j.eujim.2015.08.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Abstract
BACKGROUND Acute cerebral stroke is a common problem that is frequently associated with dysphagia resulting in an increased risk of aspiration pneumonia, complication, and mortality. METHODS A literature review was carried out using the search terms 'stroke unit and endoscopy', 'stroke unit and dysphagia', and 'stroke unit and gastroenterology'. RESULTS Only few papers focus on the role of endoscopy in stroke units. One major role is the early detection of dysphagia by flexible endoscopic evaluation of swallowing (FEES). FEES appears to have a higher sensitivity and specificity compared to bedside tests and challenges videofluoroscopy. In contrast, other stroke-associated gastrointestinal complications requiring endoscopic diagnostic or therapeutic intervention, such as gastrointestinal bleeding, abdominal pain, or stasis, and the need to provide fluid and food via gastrostomy or jejunostomy are rarely seen in stroke units and become relevant during and after the rehabilitation phase. CONCLUSION FEES should involve an interdisciplinary team comprising neurologists, speech and language pathologists and/or therapists, as well as gastroenterologic endoscopists.
Collapse
Affiliation(s)
- Thomas Frieling
- Department of Gastroenterology, Hepatology, Infectiology, Neurogastroenterology, Hematology, Oncology, and Palliative Medicine, HELIOS-Clinic Krefeld, Krefeld, Germany
| |
Collapse
|
35
|
Temporal Changes in the Quality of Acute Stroke Care in Five National Audits across Europe. BIOMED RESEARCH INTERNATIONAL 2015; 2015:432497. [PMID: 26783519 PMCID: PMC4689962 DOI: 10.1155/2015/432497] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 08/21/2015] [Accepted: 11/22/2015] [Indexed: 11/17/2022]
Abstract
Background. Data on potential variations in delivery of appropriate stroke care over time are scarce. We investigated temporal changes in the quality of acute hospital stroke care across five national audits in Europe over a period of six years. Methods. Data were derived from national stroke audits in Germany, Poland, Scotland, Sweden, and England/Wales/Northern Ireland participating within the European Implementation Score (EIS) collaboration. Temporal changes in predefined quality indicators with comparable information between the audits were investigated. Multivariable logistic regression analyses were performed to estimate adherence to quality indicators over time. Results. Between 2004 and 2009, individual data from 542,112 patients treated in 538 centers participating continuously over the study period were included. In most audits, the proportions of patients who were treated on a SU, were screened for dysphagia, and received thrombolytic treatment increased over time and ranged from 2-fold to almost 4-fold increase in patients receiving thrombolytic therapy in 2009 compared to 2004. Conclusions. A general trend towards a better quality of stroke care defined by standardized quality indicators was observed over time. The association between introducing a specific measure and higher adherence over time might indicate that monitoring of stroke care performance contributes to improving quality of care.
Collapse
|
36
|
Wiedmann S, Heuschmann PU, Hillmann S, Busse O, Wiethölter H, Walter GM, Seidel G, Misselwitz B, Janssen A, Berger K, Burmeister C, Matthis C, Kolominsky-Rabas P, Hermaneks P. The quality of acute stroke care- an analysis of evidence-based indicators in 260 000 patients. DEUTSCHES ARZTEBLATT INTERNATIONAL 2015; 111:759-65. [PMID: 25467052 DOI: 10.3238/arztebl.2014.0759] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 06/23/2014] [Accepted: 06/23/2014] [Indexed: 11/27/2022]
Abstract
BACKGROUND Stroke patients should be cared for in accordance with evidence-based guidelines. The extent of implementation of guidelines for the acute care of stroke patients in Germany has been unclear to date. METHODS The regional quality assurance projects that cooperate in the framework of the German Stroke Registers Study Group (Arbeitsgemeinschaft Deutscher Schlaganfall-Register, ADSR) collected data on the care of stroke patients in 627 hospitals in 2012. The quality of the acute hospital care of patients with stroke or transient ischemic attack (TIA) was assessed on the basis of 15 standardized, evidence-based quality indicators and compared across the nine participating regional quality assurance projects. RESULTS Data were obtained on more than 260 000 patients nationwide. Intravenous thrombolysis was performed in 59.7% of eligible ischemic stroke patients patients (range among participating projects, 49.7-63.6%). Dysphagia screening was documented in 86.2% (range, 74.8-93.1%). For the following indicators, the defined targets were not reached for all of Germany: anti-aggregation within 48 hours, 93.4% (range, 86.6-96.4%); anticoagulation for atrial fibrillation, 77.6% (range, 72.4-80.1%); standardized dysphagia screening, 86.2% (range, 74.8-93.1%); oral and written information of the patients or their relatives, 86.1% (range, 75.4-91.5%). The rate of patients examined or treated by a speech therapist was in the target range. CONCLUSION The defined targets were reached for most of the quality indicators. Some indicators, however, varied widely across regional quality assurance projects. This implies that the standardization of care for stroke patients in Germany has not yet been fully achieved.
Collapse
Affiliation(s)
- Silke Wiedmann
- Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Comprehensive Heart Failure Center (CHFC), University of Würzburg, The Clinical Trial Center, University Hospital Würzburg, German Stroke Society (DSG), Berlin, Office for Quality Assurance in Hospitals (GeQiK), Stuttgart; Baden-Württemberg Hospital Association, Stuttgart, Germany, Department of Neurology, Vivantes-Klinikum Spandau, Berlin, Department of Neurology, Asklepios Klinik Nord, Hamburg, Institute of Quality Assurance Hesse (GQH), Quality Assurance in Stroke Management in North Rhine-Westphalia, Medical Association North Rhine, Quality Assurance Project "Stroke Register Northwest Germany", Institute of Epidemiology and Social Medicine, University of Münster, Institute of Quality Assurance Rhineland-Palatinate / SQMed, Quality Association for Acute Stroke Treatment Schleswig-Holstein (QugSS), Institute of Social Medicine and Epidemiology, University of Lübeck, Erlangen Community Stroke Registry, Federal Health Reporting (GBE), Interdisciplinary Centre for Health Technology Assessment (HTA) and Public Health, Bavarian Permanent Working Party for Quality Assurance (BAQ), Munich
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Norrving B, Bray BD, Asplund K, Heuschmann P, Langhorne P, Rudd AG, Wagner M, Wiedmann S, Wolfe CDA. Cross-National Key Performance Measures of the Quality of Acute Stroke Care in Western Europe. Stroke 2015; 46:2891-5. [PMID: 26265128 DOI: 10.1161/strokeaha.115.008811] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Accepted: 07/10/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE There are no agreed measures of stroke care quality that enable the standardized comparison of stroke care between countries. We aimed to develop a set of measures of quality of acute stroke care involving stroke quality registers in Western Europe. METHODS A multinational working group identified 6 regional or national stroke quality registers in Europe and reviewed their data sets, performance measures, and the method by which these had been developed. Measures used in the registers were presented for discussion to a consensus group of representatives from the quality registers identified, as well as other stroke experts, and the final set of common performance measures was agreed through majority consensus. RESULTS Thirty final performance measures were agreed by the European consensus group, encompassing the domains of coordination of care (stroke unit-based care), diagnosis (brain imaging, vascular imaging, cardiac arrhythmia detection, and therapy assessment), preservation of neural tissue (thrombolytic therapy and door-to-needle time), prevention of complications (dysphagia screening), initiation of secondary prevention (antiplatelet, anticoagulation, lipid lowering, blood pressure lowering, carotid surgery, time from vascular imaging to carotid surgery, and smoking cessation), survival (90-day poststroke mortality), and functional outcomes (90-day modified Rankin Scale). CONCLUSIONS On the basis of experience of quality registers in Europe, we have proposed a common set of performance measures that will facilitate the international comparison of acute stroke care quality.
Collapse
Affiliation(s)
- Bo Norrving
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Benjamin D Bray
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.).
| | - Kjell Asplund
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Peter Heuschmann
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Peter Langhorne
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Anthony G Rudd
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Markus Wagner
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Silke Wiedmann
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | - Charles D A Wolfe
- From the Department of Clinical Sciences, Section of Neurology, Lund University, Lund, Sweden (B.N.); Division for Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., A.G.R., C.D.A.W.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany (P.H., S.W.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.L.); National Institute for Health Research Biomedical Research, Centre Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (A.G.R., C.D.A.W.); and Department of Integrated Care, German Stroke Foundation, Gütersloh, Germany (M.W.)
| | | |
Collapse
|
38
|
Di Carlo A, Pezzella FR, Fraser A, Bovis F, Baeza J, McKevitt C, Boaz A, Heuschmann P, Wolfe CDA, Inzitari D. Methods of Implementation of Evidence-Based Stroke Care in Europe: European Implementation Score Collaboration. Stroke 2015; 46:2252-9. [PMID: 26111887 DOI: 10.1161/strokeaha.115.009299] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2015] [Accepted: 06/02/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Differences in stroke care and outcomes reported in Europe may reflect different degrees of implementation of evidence-based interventions. We evaluated strategies for implementing research evidence into stroke care in 10 European countries. METHODS A questionnaire was developed and administered through face-to-face interviews with key informants. Implementation strategies were investigated considering 3 levels (macro, meso, and micro, eg, policy, organization, patients/professionals) identified by the framing analysis, and different settings (primary, hospital, and specialist) of stroke care. Similarities and differences among countries were evaluated using the categorical principal components analysis. RESULTS Implementation methods reported by ≥7 countries included nonmandatory policies, public financial incentives, continuing professional education, distribution of educational material, educational meetings and campaigns, guidelines, opinion leaders', and stroke patients associations' activities. Audits were present in 6 countries at national level; national and regional regulations in 4 countries. Private financial incentives, reminders, and educational outreach visits were reported only in 2 countries. At national level, the first principal component of categorical principal components analysis separated England, France, Scotland, and Sweden, all with positive object scores, from the other countries. Belgium and Lithuania obtained the lowest scores. At regional level, England, France, Germany, Italy, and Sweden had positive scores in the first principal component, whereas Belgium, Lithuania, Poland, and Scotland showed negative scores. Spain was in an intermediate position. CONCLUSIONS We developed a novel method to assess different domains of implementation in stroke care. Clear variations were observed among European countries. The new tool may be used elsewhere for future contributions.
Collapse
Affiliation(s)
- Antonio Di Carlo
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.).
| | - Francesca Romana Pezzella
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Alec Fraser
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Francesca Bovis
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Juan Baeza
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Chris McKevitt
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Annette Boaz
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Peter Heuschmann
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Charles D A Wolfe
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| | - Domenico Inzitari
- From the Institute of Neuroscience, Italian National Research Council, Florence, Italy (A.D.C., D.I.); Department of Emergency, San Camillo-Forlanini Hospital, Rome, Italy (F.R.P.); Department of Management, School of Social Science and Public Policy (A.F., J.B.) and Division of Health and Social Care Research (C.M.K.), King's College, London, United Kingdom; Department of Neurofarba, Neuroscience Section, University of Florence, Italy (F.B., D.I.); Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, London, United Kingdom (A.B.); Institute of Clinical Epidemiology and Biometry (P.H.) and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (P.H.); and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College, London, United Kingdom (C.D.A.W.)
| |
Collapse
|
39
|
Erdur H, Scheitz JF, Ebinger M, Rocco A, Grittner U, Meisel A, Rothwell PM, Endres M, Nolte CH. In-hospital stroke recurrence and stroke after transient ischemic attack: frequency and risk factors. Stroke 2015; 46:1031-7. [PMID: 25737318 DOI: 10.1161/strokeaha.114.006886] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE We aimed to assess the risk of recurrent ischemic events during hospitalization for stroke or transient ischemic attack (TIA) with optimal current management and to identify associated risk factors. METHODS We performed a retrospective analysis of all patients treated for acute ischemic stroke or TIA in 3 stroke units between 2010 and 2013. Recurrent stroke was defined as new persisting (≥24 hours) neurological deficit occurring >24 hours after the index event and not attributable to other causes of neurological deterioration. Cox proportional hazard regression identified risk factors associated with recurrent stroke. RESULTS The study included 5106 patients. During a median length of stay of 5 days (interquartile range, 4-8), stroke recurrence (or stroke after TIA) occurred in 40 patients (0.8%) and was independently associated with history of TIA, symptomatic carotid stenosis (≥70%), or other determined etiology. Patients with recurrent stroke and other determined etiology had cervical arterial dissection (n=2), primary angiitis of the central nervous system (n=1), giant cell arteritis (n=1), and lung cancer with nonbacterial thrombotic endocarditis (n=1). In patients with initial TIA or minor stroke (National Institutes of Health Stroke Scale ≤5) recurrence was associated additionally with pneumonia after the inciting ischemic event but before stroke recurrence. Patients with initial stroke and aphasia had a lower stroke recurrence rate and there were no recurrences in patients with lacunar stroke. Recurrence was associated with significantly higher in-hospital mortality (17.5% versus 3.1%; P<0.001). CONCLUSIONS In-hospital stroke recurrence was low with optimal current management. Patients with a history of TIA, severe symptomatic carotid stenosis, or uncommon causes of stroke were at higher risk. Pneumonia was associated with a higher risk of stroke recurrence in patients with initial TIA or minor stroke but not in the overall population studied. Aphasia may bias the detection rate by concealing new neurological symptoms.
Collapse
Affiliation(s)
- Hebun Erdur
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.).
| | - Jan F Scheitz
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Martin Ebinger
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Andrea Rocco
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Ulrike Grittner
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Andreas Meisel
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Peter M Rothwell
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Matthias Endres
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| | - Christian H Nolte
- From the Department of Neurology (H.E., J.F.S., M. Ebinger, A.R., A.M., M. Endres, C.H.N.), Center for Stroke Research (J.F.S., M. Ebinger, U.G., A.M., M. Endres, C.H.N.), NeuroCure, Cluster of Excellence (J.F.S., A.M., M. Endres), and Department for Biostatistics and Clinical Epidemiology (U.G.), Charité-Universitätsmedizin Berlin, Berlin, Germany; and Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom (P.M.R.)
| |
Collapse
|
40
|
Müller-Barna P, Hubert GJ, Boy S, Bogdahn U, Wiedmann S, Heuschmann PU, Audebert HJ. TeleStroke units serving as a model of care in rural areas: 10-year experience of the TeleMedical project for integrative stroke care. Stroke 2014; 45:2739-44. [PMID: 25147327 DOI: 10.1161/strokeaha.114.006141] [Citation(s) in RCA: 94] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Stroke Unit care improves stroke prognosis and is recommended for all patients with stroke. In rural areas, population-wide implementation of Stroke Units is challenging. Therefore, the TeleMedical Project for integrative Stroke Care (TEMPiS) was established in 2003 as a TeleStroke Unit network to overcome this barrier in Southeast Bavaria/Germany. Evaluation of its implementation between 2003 and 2005 had revealed improved process quality and clinical outcomes compared with matched hospitals without TeleStroke Units. Data on sustainability of these effects are lacking. METHODS Effects on the stroke care of the local population were analyzed by using data from official hospital reports. Prospective registries from 2003 to 2012 describe processes and outcomes of consecutive patients with stroke and transient ischemic attack treated in TEMPiS hospitals. Quality indicators assess diagnostics, treatment, and outcome. Rates and timeliness of intravenous thrombolysis as well as data on teleconsultations and secondary interhospital transfers were reported over time. RESULTS Within the covered area, network implementation increased the number of patients with stroke and transient ischemic attack treated in hospitals with (Tele-)Stroke Units substantially from 19% to 78%. Between February 2003 and December 2012, 54 804 strokes and transient ischemic attacks were treated in 15 regional hospitals, and 31 864 teleconsultations were performed. Intravenous thrombolysis was applied 3331 stroke cases with proportions increasing from 2.6% to 15.5% of all patients with ischemic stroke. Median onset-to-treatment times decreased from 150 (interquartile range, 127-163) to 120 minutes (interquartile range, 90-160) and door-to-needle times from 80 (interquartile range, 68-101) to 40 minutes (interquartile range, 29-59). CONCLUSIONS TeleStroke Units can provide sustained high-quality stroke care in rural areas.
Collapse
Affiliation(s)
- Peter Müller-Barna
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany.
| | - Gordian J Hubert
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Sandra Boy
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Ulrich Bogdahn
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Silke Wiedmann
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Peter U Heuschmann
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Heinrich J Audebert
- From the Department of Neurology, Klinikum Harlaching, Städtisches Klinikum München GmbH, München, Germany (P.M.-B., G.J.H.); Department of Neurology, Krankenhaus Agatharied, Hausham, Germany (P.M.-B.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (S.B., U.B.); Institute of Clinical Epidemiology and Biometry (S.W., P.U.H.) and Comprehensive Heart Failure Center (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany (S.W., P.U.H.); and Klinik und Hochschulambulanz für Neurologie (H.J.A.) and Center for Stroke Research (H.J.A.), Charité-Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
41
|
Candelise L, Gattinoni M, Bersano A. Telephone audit for monitoring stroke unit facilities: a post hoc analysis from PROSIT study. J Stroke Cerebrovasc Dis 2014; 24:196-200. [PMID: 25440337 DOI: 10.1016/j.jstrokecerebrovasdis.2014.08.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2014] [Revised: 08/15/2014] [Accepted: 08/18/2014] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND Although several valid approaches exist to measure the number and the quality of acute stroke units, only few studies tested their reliability. This study is aimed at establishing whether the telephone administration of the PROject of Stroke unIt ITaly (PROSIT) audit questionnaire is reliable compared with direct face-to-face interview. METHODS Forty-three medical leaders in charge of in-hospital stroke services were interviewed twice using the same PROSIT questionnaire with 2 different modalities. First, the interviewers approached the medical leaders by telephone. Thereafter, they went to the hospital site and performed a direct face-to-face interview. Six independent couples of trained researchers conducted the audit interviews. The degree of intermodality agreement was measured with kappa statistic. RESULTS We found a perfect agreement for stroke units identification between the 2 different audit modalities (K = 1.00; standard error [SE], 1.525). The agreement was also very good for stroke dedicated beds (K = 1.00; SE, 1.525) and dedicated personnel (K = 1.00; SE, 1.525), which are the 2 components of stroke unit definition. The agreement was lower for declared in use process of care and availability of diagnostic investigations. CONCLUSIONS The telephone audit can be used for monitoring stroke unit structures. It is more rapid, less expensive, and can repeatedly be used at appropriate intervals. However, a reliable description of the process of care and diagnostic investigations indicators should be obtained by either local site audit visit or prospective stroke register based on individual patient data.
Collapse
Affiliation(s)
- Livia Candelise
- Department of Neurological Science, University of Milan, Milan, Italy
| | - Monica Gattinoni
- Department of Neurological Science, University of Milan, Milan, Italy; Scientific Direction, IRCCS Neurological Institute C. Mondino, Pavia, Italy
| | - Anna Bersano
- Cerebrovascular Unit, IRCCS Foundation C.Besta Neurological Institute, Milan, Italy.
| | | |
Collapse
|
42
|
Handschu R, Scibor M, Wacker A, Stark DR, Köhrmann M, Erbguth F, Oschmann P, Schwab S, Marquardt L. Feasibility of Certified Quality Management in a Comprehensive Stroke Care Network Using Telemedicine: STENO Project. Int J Stroke 2014; 9:1011-6. [DOI: 10.1111/ijs.12342] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Accepted: 05/20/2014] [Indexed: 01/30/2023]
Abstract
Background Stroke care networks with and without telemedicine have been established in several countries over the last decade to provide specialized stroke expertise to patients in rural areas. Acute consultation is a first step in the management of stroke, but not the only one. Methods of standardization of care and treatment are much needed. So far, quality management systems have only been used for single stroke units. To the best of our knowledge, we are the first stroke network worldwide to aim for certification of a network-wide quality management system. Methods The Stroke Network Using Telemedicine in Northern Bavaria (STENO), currently with 20 associated medical institutions, is one of the world's largest stroke networks, caring for over 5000 stroke patients each year. In 2010, we initiated the implementation of a network-wide ‘total’ quality management system according to ISO standard 9001:2008 in cooperation with the German Stroke Society and a third-party certification organization (LGA InterCert). Results Certification according to ISO 9001:2008 was awarded in March 2011 and maintained over a complete certification cycle of 3 years without major deviation from the norm in three external third-party audits. Thrombolysis rate significantly increased from 8·2% (2009) to 12·8% (2012). Conclusions Certified quality management within a large stroke network using telemedicine is possible and might improve stroke care procedures and thrombolysis rates. Outcome studies comparing conventional stroke care and telestroke care are inevitable.
Collapse
Affiliation(s)
- René Handschu
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
- Department of Neurology, Klinikum Neumarkt, Neumarkt, Germany
| | - Mateusz Scibor
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Angela Wacker
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - David R. Stark
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Martin Köhrmann
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Frank Erbguth
- Department of Neurology, Nuremberg Municipal Academic Hospital, Nuremberg, Germany
| | - Patrick Oschmann
- Department of Neurology, Klinikum Hohe Warte Bayreuth, Bayreuth, Germany
| | - Stefan Schwab
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Lars Marquardt
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| |
Collapse
|
43
|
Rymer MM, Anderson CS, Harada M, Jarosz J, Ma N, Rowley HA, Summers D, Tastula K, Williams O, Bornstein NM. Stroke service: how can we improve and measure outcomes? Consensus summary from a global stroke forum. Acta Neurol Scand 2014; 130:73-80. [PMID: 24796345 DOI: 10.1111/ane.12256] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/03/2014] [Indexed: 11/27/2022]
Abstract
The success of acute stroke treatment is first and foremost time-dependent, and the need for improvement in acute stroke management is demonstrated by the fact that only a minority of patients gain access to treatment - in particular, intravenous recombinant tissue plasminogen activator (IV tPA) - within the necessary time window. Standards of acute stroke care vary widely both regionally and nationally; consequently, various healthcare organizations have undertaken initiatives to measure and improve quality of care. To date, most quality measures have been process-based, focusing primarily on metrics of patient care in the acute hospital-based setting (e.g., time to recombinant tPA administration). Therefore, there remains a need for metrics designed to assess how improvements in process translate into patient outcomes. A global forum was convened to share best practice and provide consensus recommendations on core metrics for measuring improvements in access to care and patient outcomes. Recommendations for core metrics of patient outcomes include hospital-based outcomes (e.g., neurological status at 24 h, ambulatory status at discharge) and post-discharge outcomes (e.g., modified Rankin Scale score at 30 and/or 90 days). Recommendations for best practice relating to aspects of people, process, and technology involved in the stroke treatment pathway that may help provide improvements in these core outcome measures are also outlined.
Collapse
Affiliation(s)
- M. M. Rymer
- The University of Kansas Hospital; Kansas City KS USA
| | - C. S. Anderson
- The George Institute for Global Health; Royal Prince Alfred Hospital; University of Sydney; Sydney NSW Australia
| | - M. Harada
- University of Tokushima; Tokushima Japan
| | | | - N. Ma
- Beijing Tiantan Hospital; Beijing China
| | - H. A. Rowley
- School of Medicine and Public Health; University of Wisconsin; Madison WI USA
| | - D. Summers
- St Luke's Neuroscience Institute; Kansas City MO USA
| | - K. Tastula
- Royal Prince Alfred Hospital; Sydney NSW Australia
| | | | - N. M. Bornstein
- Tel-Aviv Medical Center; Tel-Aviv University; Tel-Aviv Israel
| |
Collapse
|
44
|
Kwok CS, Musgrave SD, Price GM, Dalton G, Myint PK. Similarity of patient characteristics and outcomes in consecutive data collection on stroke admissions over one month compared to longer periods. BMC Res Notes 2014; 7:342. [PMID: 24906247 PMCID: PMC4077680 DOI: 10.1186/1756-0500-7-342] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2013] [Accepted: 09/19/2013] [Indexed: 11/10/2022] Open
Abstract
Background The usefulness of time-limited consecutive data collection compared to continuous consecutive data collection in conditions which show seasonal variations is unclear. The objective of this study is to assess whether one month of admission data can be representative of data collected over two years in the same hospitals. Methods We compared the baseline characteristics and discharge outcomes of stroke patients admitted in the first month (October 2009) of the Anglia Stroke Clinical Network Evaluation Study (ASCNES) with the routinely collected data over 2 years between September 2008 and April 2011 from the same 8 hospital trusts in the Anglia Stroke & Heart Clinical Network (AS&HCN) as well as seasonal cohorts from the same period. Results We included a total of 8715 stroke patients (October 2009 cohort of ASCNES (n = 308), full AS&HCN cohort (n = 8407 excluding October 2009)) as well as cohorts from different seasons. All cohorts had a similar median age. No significant differences were observed for pre-stroke residence, pre-stroke modified Rankin, weekend vs. weekday admission, time of admission, patients with atrial fibrillation, type of stroke, admission systolic blood pressure, use of thrombolysis (rTPA), in-patient mortality and discharge destination. There were statistically significant differences between cohorts with regard to Oxfordshire Community Stroke Project Classification. Conclusions Stroke patients admitted in one month had largely indistinguishable characteristics and discharge outcomes to those admitted to the same trusts in three separate seasons and also over two years in this cohort.
Collapse
Affiliation(s)
- Chun Shing Kwok
- Faculty of Medicine & Health Sciences, Norwich Medical School, Norwich Research Park, Norwich, UK.
| | | | | | | | | | | |
Collapse
|
45
|
Quality indicators in acute stroke care: a prospective observational survey in 13 Italian regions. Aging Clin Exp Res 2014; 26:279-86. [PMID: 24293350 DOI: 10.1007/s40520-013-0171-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2013] [Accepted: 11/11/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND AND AIMS Quality monitoring has great relevance in stroke care. The Project "How to guarantee adherence to effective interventions in stroke care" aimed to estimate adherence to acute-phase guidelines in stroke care in Italy. METHODS A prospective observational study was performed in 27 hospitals of 13 Italian Regions. Adherence to 15 process indicators was evaluated, comparing also stroke units (SU) with conventional wards. An overall score of care, defined as the sum of achieved indicators, was calculated. A multilevel hierarchical model described performance at patient, hospital and regional level. RESULTS Overall, 484 consecutive stroke patients (mean age, 73.4 years; 52.7 % males) were included. Total score ranged from 2 to 15 (mean 8.5 ± 2.4). SU patients were more often evaluated with the National Institutes of Health Stroke Scale (NIHSS) within 24 h, had more frequently an assessment of pre- and post-stroke disability, and a CT scan the same or the day after admission. Regional-hospital- and patient-level variability explained, respectively, 25, 34, and 41 % of total score variance. In multivariate models, patients >80 years vs. younger showed a change in total score of -0.45 (95 % CI -0.79 to -0.12), and those with NIHSS ≥14 vs. ≤5 of -0.92 (95 % CI -1.53 to -0.30). A negative change means a worse adjusted average adherence to process indicators. SU admission increased total score of 1.55 (95 % CI 0.52-2.58). CONCLUSIONS Our data confirm the need of quality monitoring in stroke care. Although SU patients showed a better adherence to quality indicators, overall compliance was unsatisfactory.
Collapse
|
46
|
Hall RE, Khan F, Bayley MT, Asllani E, Lindsay P, Hill MD, O'Callaghan C, Silver FL, Kapral MK. Benchmarks for acute stroke care delivery. Int J Qual Health Care 2013; 25:710-8. [PMID: 24141011 PMCID: PMC3842126 DOI: 10.1093/intqhc/mzt069] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/07/2013] [Indexed: 12/18/2022] Open
Abstract
OBJECTIVE Despite widespread interest in many jurisdictions in monitoring and improving the quality of stroke care delivery, benchmarks for most stroke performance indicators have not been established. The objective of this study was to develop data-derived benchmarks for acute stroke quality indicators. DESIGN Nine key acute stroke quality indicators were selected from the Canadian Stroke Best Practice Performance Measures Manual. PARTICIPANTS A population-based retrospective sample of patients discharged from 142 hospitals in Ontario, Canada, between 1 April 2008 and 31 March 2009 (N = 3191) was used to calculate hospital rates of performance and benchmarks. INTERVENTION The Achievable Benchmark of Care (ABC™) methodology was used to create benchmarks based on the performance of the upper 15% of patients in the top-performing hospitals. MAIN OUTCOME MEASURES Benchmarks were calculated for rates of neuroimaging, carotid imaging, stroke unit admission, dysphasia screening and administration of stroke-related medications. RESULTS The following benchmarks were derived: neuroimaging within 24 h, 98%; admission to a stroke unit, 77%; thrombolysis among patients arriving within 2.5 h, 59%; carotid imaging, 93%; dysphagia screening, 88%; antithrombotic therapy, 98%; anticoagulation for atrial fibrillation, 94%; antihypertensive therapy, 92% and lipid-lowering therapy, 77%. ABC™ acute stroke care benchmarks achieve or exceed the consensus-based targets required by Accreditation Canada, with the exception of dysphagia screening. CONCLUSIONS Benchmarks for nine hospital-based acute stroke care quality indicators have been established. These can be used in the development of standards for quality improvement initiatives.
Collapse
Affiliation(s)
- Ruth E Hall
- Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, G wing, G-106, Toronto, Ontario, M4N 3M5, Canada.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Minaya-Muñoz F, Medina-Mirapeix F, Valera-Garrido F. Quality measures for the care of patients with lateral epicondylalgia. BMC Musculoskelet Disord 2013; 14:310. [PMID: 24172311 PMCID: PMC3816543 DOI: 10.1186/1471-2474-14-310] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2013] [Accepted: 10/23/2013] [Indexed: 11/23/2022] Open
Abstract
Background Lateral epicondylalgia (LE) defines a condition of varying degrees of pain near the lateral epicondyle. Studies on the management of LE indicated unexplained variations in the use of pharmacologic, non-pharmacological and surgical treatments. The main aim of this paper was to develop and evaluate clinical quality measures (QMs) or quality indicators, which may be used to assess the quality of the processes of examination, education and treatment of patients with LE. Methods Different QMs were developed by a multidisciplinary group of experts in Quality Management of Health Services during a period of one year. The process was based following a 3-step model: i) review and proportion of existing evidence-based recommendations; ii) review and development of quality measures; iii) pilot testing of feasibility and reliability of the indicators leading to a final consensus by the whole panel. Results Overall, a set of 12 potential indicators related to medical and physical therapy assessment and treatment were developed to measure the performance of LE care. Different systematic reviews and randomized control trials supported each of the indicators judged to be valid during the expert panel process. Application of the new indicator set was found to be feasible; only the measurement of two quality measures had light barriers. Reliability was mostly excellent (Kappa > 0.8). Conclusions A set of good practice indicators has been built and pilot tested as feasible and reliable. The chosen 3-step standardized evidence-based process ensures maximum clarity, acceptance and sustainability of the developed indicators.
Collapse
Affiliation(s)
- Francisco Minaya-Muñoz
- MVClinic, Juan Antonio Samaranch Torelló St,, 6B, Fitness Sports Center Valle de Las Cañas, 28223, Pozuelo de Alarcón, Madrid, Spain.
| | | | | |
Collapse
|
48
|
Bodechtel U, Puetz V. Why Telestroke networks? Rationale, implementation and results of the Stroke Eastern Saxony Network. J Neural Transm (Vienna) 2013; 120 Suppl 1:S43-7. [DOI: 10.1007/s00702-013-1069-y] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2013] [Accepted: 07/06/2013] [Indexed: 11/28/2022]
|
49
|
Hristova Popova K. Evidence-based guidelines in Bulgaria: A new frontier for management of stroke in primary care. INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT 2013. [DOI: 10.1179/2047971911y.0000000003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
50
|
Catumbela E, Certal V, Freitas A, Costa C, Sarmento A, da Costa Pereira A. Definition of a core set of quality indicators for the assessment of HIV/AIDS clinical care: a systematic review. BMC Health Serv Res 2013; 13:236. [PMID: 23809537 PMCID: PMC3735478 DOI: 10.1186/1472-6963-13-236] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2012] [Accepted: 06/19/2013] [Indexed: 11/24/2022] Open
Abstract
Background Several organizations and individual authors have been proposing quality indicators for the assessment of clinical care in HIV/AIDS patients. Nevertheless, the definition of a consensual core set of indicators remains controversial and its practical use is largely limited. This study aims not only to identify and characterize these indicators through a systematic literature review but also to propose a parsimonious model based on those most used. Methods MEDLINE, SCOPUS, Cochrane databases and ISI Web of Knowledge, as well as official websites of organizations dealing with HIV/AIDS care, were searched for articles and information proposing HIV/AIDS clinical care quality indicators. The ones that are on patient’s perspective and based on services set were excluded. Data extraction, using a predefined data sheet based on Cochrane recommendations, was done by one of the authors while a second author rechecked the extracted data for any inconsistency. Results A total of 360 articles were identified in our search query but only 12 of them met the inclusion criteria. We also identified one relevant site. Overall, we identified 65 quality indicators for HIV/AIDS clinical care distributed as following: outcome (n=15) and process-related (n=50) indicators; generic (n=36) and HIV/AIDS disease-specific (n=29) indicators; baseline examinations (n=19), screening (n=9), immunization (n=4), prophylaxis (n=5), HIV monitoring (n=16), and therapy (=12) indicators. Conclusions There are several studies that set up HIV clinical care indicators, with only a part of them useful to assess the HIV clinical care. More importantly, HIV/AIDS clinical care indicators need to be valid, reliable and most of all feasible.
Collapse
Affiliation(s)
- Emanuel Catumbela
- Department of Health Information and Decision Sciences, Faculty of Medicine, University of Porto, Al, Prof, Hernâni Monteiro, Porto, 4200-319, Portugal.
| | | | | | | | | | | |
Collapse
|